Biochemical and Functional Analysis of the PREP1 Interactor: p160 Myb Binding Protein 1 by Mori, Silvia
Open Research Online
The Open University’s repository of research publications
and other research outputs
Biochemical and Functional Analysis of the PREP1
Interactor: p160 Myb Binding Protein 1
Thesis
How to cite:
Mori, Silvia (2010). Biochemical and Functional Analysis of the PREP1 Interactor: p160 Myb Binding Protein
1. PhD thesis The Open University.
For guidance on citations see FAQs.
c© [not recorded]
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
o s j R C S T i e  t c r c .  &
Silvia Mori
O pen U niversity  Personal Identifier : Y 7046930 
U n iversita’ V ita-Salute San R affaele Personal Identifier: 002105
BIOCHEMICAL AND FUNCTIONAL 
ANALYSIS OF THE PREP1 
INTERACTOR: pl60 MYB BINDING 
PROTEIN 1
Degree of Doctor of Philosophy (PhD) 
in Molecular and Cellular Biology
November 2010
DIBIT
Department of Molecular Genetics 
Universita Vita-Salute San Raffaele 
Milan -  Italy
Director of Studiejs Second Supervisor
Francesco Blasi Jesper Svejstrup
op soerwssion: Zo Sep' zo \a  
o p  3  ^ 0 , 0
ProQuest Number: 13837641
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 13837641
Published by ProQuest LLC(2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
TABLE OF CONTENTS
D E C L A R A T IO N .......................................................................................................................................4
A B S T R A C T .................................................................................................................................................5
IN T R O D U C T IO N .................................................................................................................................... 6
1. The nucleolar  protein Pi 60 m yb  binding  protein 1a ..................................................6
1.1 The nucleo lus.............................................................................................................................. 6
1.2 p l6 0 .........................................................................................   11
1.3 p 160 interactors........................................................................................................................ 14
2. The Hom eodom ain transcription  factor  PrepI .......................... 4..............................15
2.1 Homeodomain class o f  transcription factors.................................................................. 15
2 .1.1 Hox Family........................................................................................................................ 17
2 .1.2 TALE fam ily ...................................................................................................................... 17
2.2 P r e p l ............................................................................................................................................19
2.2.1 Prepl cooperates with other transcription factors ............................................. 22
2 .2 .2  Prepl interactors............................................................................................................23
3. Cell-Cycle regulation ............................................................................................................25
3.1 C e ll-cy cle .....................................................................................................................   25
3.2 M itosis.........................................................................................................................................28
3.3 C ell-cycle regulation: the importance o f  Cyclin-dependent kinases -  cyclins 
com plexes.......................................................................................................................................... 31
3.3.1 Interphase regulation.................................................................................................... 31
3.3.2 Mitosis regulation...........................................................................................................32
3.3.3 Checkpoints................................................ 33
A IM  O F  T H E  W O R K ......................................................................................................................... 36
M A T E R IA L  A N D  M E T H O D S........................................................................................................ 37
1. Cell Culture a n d  tr eatm ents .............................................................................................37
1.1 Cell culture................................................................................................................................ 37
1.2 Treatments..................................................................................................................................37
2. Plasm ids  u se d .................................................................................................................................38
2.1 Preparation o f  Prepl-G ST deletion and point m utants............................................39
3. Tr a nsien t  tr ansfectio n .......................................................................................................... 41
1
3.1 Transient p i 60 silencing in HeLa ce lls ............................................................................41
j 4. G eneration  of retroviruses/lentiviruses a n d  infection  of NIH  3T3 c ells .42
4.1 Retroviral infection and selection o f  stable c lo n e s ......................................................42
4.2  Lentiviral infection and selection o f  stable p i  60 c lon es............................................42
5. Protein ex t r a c tio n .............................................................................   43
5.1 Total protein extraction......................................................................................................... 43
5.2 Cytoplasmic and Nuclear protein extraction..................................................................44
| 6. W estern  B lot a n a l y s is  ..........................................................................................  44
7. IMMUNOPRECIPITATION..................................................................................................................45
8. In  vitro transcription-translation ..................................................................................46
9. Pull-do w n  a s s a y ........................................................................................................   46
10. Luciferase  a s s a y .......................................................................................................................47
11.E M S A ............................................................................................................................................... 47
12. R N A  EXTRACTION......................................................................................................................... 48
13. Rea l-T ime P C R ............................................................................................................................48
14. Imm unofluorescence an d  confocal microscopy  a n a l y s is ................................50
14.1 Im m unoFISH ......................................................................................................................... 51
; 15. Proliferation a s s a y ..................................................................................................................53
15.1 Crystal V iolet a s sa y .............................................................................................................53
16. Flow -C itometry a n a l y sis .................................................................................................... 53
16.1 EdU /7A A D  staining.............................................................................................................53
16.2 Annexin V  sta in in g .............................................................................................................:54
17. T ime-Lapse  m icroscopy ...........................................................................................................54
| 18. K a r y o t y p in g .................................................................................................................................55
19. Gene Expression  Profiling ..............................................................................................  55
20. Soft-a g a r  a s s a y ........................................................................................................................ 57
RESULTS........................................................................................................................ 58
1. B iochemical a n d  functional a n alysis  of the Pr ep1-p 160MBP interaction 58
1.1 Prep 1 co-immunoprecipitates with p 1 6 0 ........................................................................ 58
1.2 Prepl and p i 60 directly interact in vitro......................................................................... 59
1.3 Identification o f  the p i 60 binding site on P re p l.......................................................... 61
1.4 Identification o f  the Prepl binding region in p i 6 0 ......................................................63
2
1.5 p i 60 com petes with Pbx for the binding to Prepl and inhibits its transcriptional 
activity.................................................................................................................................................65
1.6 p i 60 interacts with Prepl in the n u c leu s........................................................................ 68
2. Cell-cycle defects in  p 160-depleted  cells................................................................... 75
2.1 The nucleolar protein p i 60 distributes in a para-chromosomal region during 
m ito sis .................................................................................................................................................75
2.2 p i 60 knock-down determines proliferation defects.....................................................80
2.3 p l60-depleted  cells have a higher degree o f  apoptosis.............................................. 84
2.4 p l60-depleted  cells display a variety o f  the cell-cycle d efects................................86
2.4.1 pl60-depleted cells accumulate in the G2/M phase o f  the cell-cycle......... 86
2.4.2 Mitosis structural alterations in pl60-depleted cells ........................................ 87
2.5 In p i 60 silenced cells m itosis is slow ed d o w n ............................................................. 91
2.6 N o variability in karyotype for p i 60 down-regulated c e lls ......................................93
2.7 Gene expression profiling in p l60-depleted  HeLa c e lls ............................................94
2.7.1 Microarray experiment.................................................................................................94
2.7.2 Validation o f Gene Expression experiment by Real-Time PCR ......................96
3. Role of p 160 in tu m o r ig en esis ...................................................................................  100
3.1 Fifty percent reduction o f  p i  60 does not result in changes in the cell-cycle... 100
3.2 A  small reduction in p i 60 level favors cell transformation....................................101
D IS C U S S IO N ........................................................................................................................................ 107
1. P i60 IS A DIRECT PREPl INTERACTOR THAT INHIBITS ITS TRANSCRIPTIONAL ACTIVITY
 ........................................................................................................................................................ 108
2. P i60 IS INVOLVED IN CELL-CYCLE REGULATION.................................................................. 109
3. P i60 IS A PUTATIVE TUMOR SUPPRESSOR................................................................................112
Concluding  remarks a n d  future per spec tiv es ..............................................................114
A P P E N D IX ............................................................................................................................................. 117
I. Study  of P160MBP sum o y la tio n ........................................................................................ 117
II. List of figures /  ta b les ...........................................................................................................123
III. List of a bbreviatio n s ....................................................................................................   125
R E F E R E N C E S ......................................................................................................................................128
A C K N O W L E D G M E N T S ................................................................................................................143
3
DECLARATION
This PhD Thesis has been written by myself and has not been used in any previous 
application for a degree. All the results presented are original data and were obtained in 
the laboratory of Molecular Genetics (DIBIT - San Raffaele Scientific Institute, Milan), 
under the guidance of Professor Francesco Blasi. For scientific completeness, some data, 
obtained in collaboration with other laboratories, are presented and they are clearly 
identified at the end of the pertaining result chapter. Some of the work showed in this 
Thesis has been published and the relative reference is reported at the end of the relative 
result chapter.
4
ABSTRACT
p i60 myb binding protein la  (p i60) is a nucleolar protein the function of which is 
poorly understood. To date, only a few interactors, mainly transcription factors (e.g. 
Myb, Jun), have been characterized. One of these is Prepl, an homeodomain 
transcription factor essential for embryonic development, involved, in particular, in 
haemopoiesis, angiogenesis, and oculogenesis, as well as in apoptosis and 
tumorigenesis. In this thesis work I show that p i 60 is capable of binding Prepl through 
the same region as another Prepl interactor, Pbx, and that such binding inhibits Prepl 
action on the HoxB enhancer. I demonstrate that the two proteins, Prepl and p i60, 
interact mainly in the nucleoplasm and hence only under conditions that favor p i60 
translocation from the nucleolus to the nucleoplasm (e.g. after treatment with 
Actinomycin D).
Moreover I studied p i60 during cell-cycle, since during mitosis p i60 assumes a para- 
chromosomal localization. In HeLa cells, depletion of p i60 by siRNA transfection 
decreases the proliferation rate and increases cell-death, mostly via apoptosis. p i 60- 
depleted HeLa cells accumulate in the G2/M phases of the cell-cycle and show a variety 
of mitotic defects: extended division time and structural alterations of the metaphasic 
plate. All these data suggest that p i60 is essential for proper cell division. This 
phenotype is also in agreement with my observations that p i60 down-regulated NIH 
3T3 cells are more sensitive to transformation by Ras and Myc and undergo spontaneous 
neoplastic transformation even in the absence of oncogenes.
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IINTRODUCTION
In my thesis work I studied the interaction between the nucleolar protein p i60 and the 
homeodomain transcription factor Prepl, trying to elucidate p i60 function. In this first 
section I will describe these two interactors and the main cellular process involved: the 
cell-cycle.
1. The nucleolar protein pl60 myb binding protein la
1.1 The nucleolus
The nucleolus is an extremely organized sub-nuclear compartment whose main 
functions are rRNA synthesis and ribosome assembly. It is an almost spherical structure 
surrounded by a layer of condensed chromatin and not by a membrane. The nucleolus is 
composed of three layers (Alberts B. et al., 1994) (Fig. 1):
- the Fibrillar Center (FC), which is made up of a network of fine fibrils and does not 
contain actively transcribed DNA;
- the Dense Fibrillar Component (DFC), surrounding the FC, is the site of rDNA genes 
transcription and pre-rRNAs modification;
- the Granular Component (GC), surrounding the fibrillar complexes at the border with 
the chromatin and nucleoplasm, is the site of ribosome subunits assembly.
6
Nucleoli originate from the nucleolar organizing region (NOR), that contains rDNA 
genes arranged in head-to-tail tandem  repeats located on acrocentric chrom osom es [11]. 
The dim ension and the num ber o f  nucleoli vary from cell to cell but, in general, they are 
bigger in actively proliferating cells, as they need active protein synthesis.
NUCLEOLUS
GC
DFC
NUCLEOPLASM
CYTOPLASM
Fig. 1 Nucleolar organization. Schematic representation o f the nucleolus: Fibrillar Component 
(FC), Dense Fibrillar Component (DFC) and Granular Component (GC) are indicated.
Nucleoli undergo cycles o f  disassem bly and reassem bly each tim e the cell undergoes 
m itosis. In fact, there are no visible nucleoli during m etaphase [11]. During prophase the 
com plex cyclin B l-cyclin  dependent kinase 1 (CDK1) hyper-phosphorylates the 
nucleolar RNA polym erase I initiation com plex and this determ ines nucleolar 
disassembly and this event takes place in concom itance with nuclear envelope 
disassembly [73]. Some nucleolar proteins remain attached to the surface o f  condensed 
chromosomes, in a region called Perichromosomal Region (PR), while others are
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released in the nucleoplasm [39]. In the PR there are rRNA processing components: 
ribonucleoproteins (RNPs), small nucleolar RNA U3 (U3 snoRNA), pre-RNA and 
fibrillarin [25]. The function of the PR is still not clear, but it might serve to isolate 
chromosomes from cytoplasm or function as a binding site for chromosomal passenger 
proteins or favour an equal distribution of nucleolar components in the two daughter 
cells [48]. In anaphase, nucleolar proteins remain either attached to the chromosomes or 
in Nucleolar Derived Foci (NDF) in the cytoplasm. At the onset of telophase there is a 
reduction of the cyclin B1/CDK1 complex that determines the reactivation of the rRNA 
transcription and the reassembly of the nucleolus. NDF disassemble and the nucleolar 
proteins are transferred to fibrogranular structures on the surface of chromosomes (pre- 
nucleolar bodies, PNBs) and on nucleolar organizing regions. As soon as nucleoli 
reassemble PNBs transfer their content to nucleoli [115] (Fig. 2).
The main nucleolar function is ribosome biogenesis. The first step of this activity 
consists in the transcription of rDNA by RNA polymerase I at the border between FC 
and DFC. The 45S rRNA precursor is produced and cleaved into 28S, 18S and 5,8S 
rRNAs that are post-transcriptionally modified at the level of DFC. These products 
interact with small nucleolar ribonucleoproteins (snoRNPs) and are subsequently 
assembled with other ribosomal proteins. The last step is the interaction with the export 
machinery in the nucleolar GC region and the transport to the cytoplasm [31,126] (Fig.
3).
8
Nucleus
a  Early prophase
Cytoplasm  cyclin  B1—CDK1 T
C M etaphase
O
^DTCO.
GC
Nucleus'
b  Late prophase
e Early te loph ase f  Late telophase
O rRNA transcription machinery ^  Decondensed chromosomes
O Early rRNA-processing proteins ~ _ ~ Condensed chromosomes
O Late rRNA-processing proteins PN3
—  Partially processed prc-rRNA NDF
PR or sheet Mitotic spindle
Nature Reviews | Molecular Cell Biology
Fig. 2 Nucleolar assembly and disassembly in mitosis. Schematic representation o f the 
nucleolar components during the different mitotic phases [11].
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Fig. 3 The assembly of ribosomes. Schematic representation of ribosomes generation: 
transcription, association with ribonucleoproteins, maturation and transport into the cytoplasm 
(Alberts B. et al., 1994).
The nucleolus participates in other cellular processes as well: cell-cycle control, stress 
response and coordination o f  the biogenesis o f  other classes o f  RNPs. In particular, 
several nucleolar proteins are involved in cell-cycle regulation or are fundamental for 
cell division. N ucleophosm in is essential for chrom osom es congression, mitotic spindle, 
centrosom es formation and proper kinetocore-m icrotubules attachm ent [2,43], RNA 
m ethyltransferase Misu (NSun2) is a substrate for A urora B kinase and during m itosis is
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required for proper spindle assembly and chromosome segregation [53,113]. SENP5, a 
SUMO protease, prevents inhibition of cell proliferation and its absence causes defects 
in nuclear morphology and problems in cytokinesis [21]. The nucleolus is also a sensor 
for cellular stress, stabilizing p53 through the sequestration of HDM2 (E3 ubiquitin 
ligase) in the nucleolus by p 14ARF [132].
The nucleolus is also involved in many diseases in which proteins are sequestered in 
nucleoli (Werner syndrome, Bloom syndrome [84]) or in which there is an altered 
ribosomes biogenesis for mutations in ribosomal proteins (Diamond-Blackfan anemia, 
dyskeratosis [19,47]). It may also be involved in viral infections since some viruses 
target nucleoli and alter their function. Moreover, alterations in the level of nucleolar 
proteins can determine cell transformation: NPM, if present at low levels, determines 
genomic instability which favours cell transformation [43]. In addition nucleoli are 
currently used as a prognostic marker for tumor progression: the bigger the nucleoli, the 
faster will be the tumor progression [20].
1.2 pl60
p i60 Myb binding protein la  was identified as an interactor of Myb [32]. In particular, 
p i 60 binds a leucine-zipper motif of the negative regulatory domain (NDR) of Myb that 
is essential because it mediates DNA binding, transactivation and transformation 
[27,51,59,108]. pl60 binds but does not inhibit Myb function. pl60 is ubiquitously 
expressed, in particular in fetal liver cells that are highly proliferating and this might be 
indicative of a role in proliferation [124]. It was also found a shorter form of p i60, 
named p67, that derives from proteolitic cleavage of the protein and it is present in a
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small subset of cells, in particular in some immature myeloid cells. p67 represents the N- 
terminal part of pi 60 and can bind Myb through the same NDR, but, differently from the 
whole-length protein, it is also capable of inhibiting Myb’s transactivating function 
[32,124].
The p i60 gene is located on chromosome 11 in mouse and on chromosome 17pl3.3 in 
human [61]. The p i60 human gene has an interesting localization because this region is 
frequently affected (50-80%) in loss of heterozygosity in different malignancies like: 
sporadic breast and ovarian cancer, medulloblastomas, astrocytomas, osteosarcomas, 
and leukemia, etc. [103,114,121,123].
p i60 is highly conserved across species [61] and also has an homolog in yeast: POL5, 
which is the fifth essential DNA polymerase in Saccharomyces cerevisiae. POL5 is a 
nucleolar protein with low polymerase activity, that is essential for cell growth because 
it plays a poorly understood role in rRNA synthesis, binding near or at the enhancer 
region of rDNA repeating units [119]. POL5 has a high degree of similarity with the N- 
terminal and middle part of p i 60 [135] (Fig. 4, red lines).
The p i60 structure presents a central acidic domain whose function is unknown, two 
putative leucine zipper-like motifs (starting at amino acids 307 and 900) and several 
Leucine Charged Domains (LCD), important for protein-protein interaction, probably 
essential for the binding of p i 60 to c-Myb and c-Jun. There are also seven short basic 
amino acid sequences embedded in a proline-serine-rich region at the C-terminus that 
are required for the nuclear and nucleolar localization (Fig. 4) [62]. p i60 can bind 
importin a through this region and can be imported into the nucleus by way of the 
importin a/p heterodimer, p i60 is predominantly found in the nucleolus and only a small
12
fraction in the nucleoplasm [124]. P I60 can also translocate to the cytoplasm via the 
leucine-rich motifs (LCD and leucine zipper-like domains) that can function as export 
signals as they are recognized by the nuclear export receptor CRM1 [62].
307L-L-L“I-NI335 900L-L-Q-L-L928
NH, COOH
200 400 600 800 1000 1200
Fig. 4 p l60  structure. Schematic representation o f p i60; L, leucine zipper-like domain; A, 
acidic domain; *, basic amino acid repeat motifs; solid lines, LCD (LXXLL motif) [62]; 
horizontal lines represent the POL5 homology regions.
Yamauchi et al., demonstrated that after ribosomal stress (e.g. treatment with 
Actinomycin D) p i60 is processed into two shorter forms: p67 and p i40 that lacking the 
nucleolar localization signal, translocate to the nucleoplasm [134]. They also identified 
two p i60 containing complexes that might be important for its function. The small 
complex contains p i40, p67, Nucleolin, Nucleophosmin (NPM) and EBP1, while the 
large complex contains p i40, Nucleolin and NPM, and in addition Topoisomerase I, 
Nucleostemin, Histone H lx and ribosomal subunit proteins. The latter complex is 
interesting because Nucleolin, NPM and Nucleostemin are known to stimulate ribosome 
biogenesis through their involvement in rRNA transcription, ribosome maturation and 
assembly and transport of ribosomes [44,91]. This might be indicative of an involvement 
of this complex and consequently of p i60, in ribosome biogenesis, and is supported by
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the high degree of similarity the p i60 shares with yeast POL5, which in turn is essential 
for rRNA synthesis [119]. They also hypothesized that the translocation of the small 
complex (containing p67 and p i40) to the nucleoplasm allows the interaction of p67 
with transcription factors, such as c-Myb, and consequently regulates cell-cycle 
progression, proliferation and apoptosis.
Finally, upon proteasome inhibition, p i60 was detected among the endogenous 
sumoylated proteins and this post-translational modification may be important in 
defining p i60 function and/or fate (Appendix I, [85]).
Another hint on p i60 function is its particular localization during mitosis. In fact a 
proteomic analysis of the chromosome scaffold fraction revealed that p i60 was located 
on chromosome arms [38].
1.3 pl60 interactors
Although the function of p i 60 is still not clear, several interactors were characterized. It 
was originally identified as an interactor of c-Myb, a transcription factor that plays an 
essential role in controlling proliferation and differentiation of hematopoietic cells, 
where p i60 might act as a co-regulator [124].
P I60 can also interact with the leucine-zipper domain of another transcription factor, c- 
Jun, but the function of this interaction is not clear [32].
Another interactor is the transcription factor PPAR gamma co-activator la  (PGCla), a 
key regulator of mammalian energy metabolism. P I60 binds the negative regulatory 
domain of PGCla and inhibits its transcriptional activity. When p38 MAPK
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phosphorylates PGCla, the binding of p i60 is inhibited and the transcription factor can 
exert its function [30].
p i60 binds also to the acidic activation domain of the aromatic hydrocarbon receptor 
(AhR, a bHLH/Per-Amt-Sim transcription factor, together with its partner Amt) and 
increases transcriptional activation [57].
Another p i60 interactor is RelA/p65, a member of the NF-kB family of inducible 
transcription factors that regulates cell-cycle, proliferation and apoptosis. p i60 binds the 
transcription activation domain of RelA/p65 and represses its activity by competing with 
the binding of the transcription co-activator p300 [97].
The last interactor found is Prepl (see below). The lack of this interaction in Prepl 
hypomorphic mice (Prepl171) renders their skeletal muscle more sensitive to insulin and 
the mice are protected from diabetes. Indeed Prepl seems to protect p i60 from 
degradation; thus a decrease in Prepl levels causes a decrease of p i 60 levels. Since p i 60 
is also a repressor of PGCla, its decrease increases the activity of PGCla and activates 
glucose uptake [96].
2. The Homeodomain transcription factor Prepl
2.1 Homeodomain class of transcription factors
Transcription factors are characterized by the presence of at least two domains: a DNA- 
binding domain and a trans-activating domain [72]. They are grouped in families 
according to the structure of their DNA-binding motif (Alberts B. et al., Molecular
15
biology of the cell, 1994), one of which is the Helix-Tum-Helix (HTH) class, 
characterized by two a-helices connected with a small amino acidic chain. 
Homeodomain proteins, which are required for the development of every single area of 
the organism and are coded by the Hox gene cluster, belong to this class [90]. The term 
homeodomain originates from a homeotic mutation of Drosophila melanogaster gene 
Antennapedia (Antp) that determines the switch of one body segment to another, 
inducing the development of legs in the place of antennae [82,83,90]. The homeodomain 
proteins are characterized by a conserved 60 amino acids DNA-binding motif (coded by 
180 nucleotides homeobox), known as the homeodomain (HD). X-ray crystallography 
and Nuclear Magnetic Resonance (NMR) studies indicate that the HD has a HTH 
structure with three distinct a-helices. The recognition helix, at the Carboxyl-terminus 
(C-terminal) of the motif, contacts DNA in the major groove and makes specific base 
pair contacts, whereas the Amino-terminus (N-terminal) moiety makes contact with the 
minor groove [40,41]. The association of homeobox proteins between themselves 
increases their DNA-binding specificity. Based on the similarities in the motifs outside 
the HD, Homeodomains proteins are classified as follow:
> Hexapeptide class, includes the Hox family, in which all proteins have an N- 
terminal 6 amino acids protein interaction domain [40].
> TALE (Three Amino acid Loop Extension) class, which includes Pbx and 
Meis/Prep proteins with an atypical HD [14,90].
> POU class, which includes the Octamer family and contains the N-terminal 
POU bipartite DNA-binding domain. It consists of two highly conserved
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regions connected by a variable linker, in addition to the homeodomain 
[40,117].
>  LIM  class, which, in addition to the homeodomain, contains an N-terminal 
LIM metal binding protein-protein interaction domain [40,58].
2.1.1 Hox Family
The main function of Hox genes products is to pattern the anterior-posterior body axis of 
embryos [69,76]. These proteins share a short tryptofan-containing hexapeptide motif 
with the consensus IYPWMK or ANW, located N-terminal of the HD that is required to 
bind specifically the TALE motif (see below) [16,18,66,102,104]. Hox proteins have a 
weak DNA-binding capacity, hence in order to bind and regulate their target genes, they 
need such co-factors as the TALE proteins [81,90].
2.1.2 TALE family
The TALE family of proteins is divided into 2 classes:
>  the PBC proteins which comprise Pbx (preB cell homeobox) in mammals, 
Exd (Extradenticle) in Drosophila, Lzr (Lazarus) in Zebrafish and CEH-20 in 
Caenorhabditis Elegans;
>  the MEINOX proteins with Prep (Pbx-regulating protein) and Meis (Myeloid 
ecotropic viral integration site) in mammals, Hth (Homothorax) in 
Drosophila and UNC-62 in Caenorhabditis Elegans.
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In Fig. 5 is shown the schematic structure of PBC and MEINOX members. All TALE 
members show a divergent HD containing a proline (P) -  tyrosine (Y) -  proline (P) 
motif in position 24-26 between the first and the second a-helix, through which they 
contact the hexapeptide motif of Hox proteins increasing their affinity for DNA [14,15]. 
Pbx proteins contain an additional DNA binding a-helix located C-terminally to the HD 
(a4-HCM) [104]. N-terminally to the HD, the PBC proteins have two conserved 
domains: PBC-A and PBC-B, the first of which mediates the interaction with MEINOX 
proteins [15,112]. Also MEINOX proteins have two conserved domains: HM1 or HR1 
(Homology Region 1) and HM2 or HR2 (Homology Region 2) that are conserved in the 
two Prep and Meis subclasses and make contacts with Pbx proteins [15,90]. Moreover 
several Hox genes can interact directly with Meis proteins through the C-terminal region 
(CTD) of Meis that includes the HD [130].
PBC proteins are considered Hox cofactors because they interact directly with Hox 
proteins increasing their affinity for DNA and determining the DNA binding specificity 
and selectivity [90]. PBC proteins can heterodimerize with Hox proteins only in the 
presence of DNA and are able to bind the sequence TGATNNAT [22,105].
MEINOX proteins act by modifying the PBC-Hox complex binding activity, extending 
its potential regulatory role.
18
PBX1
PBC-A PBC-B
PBC-A PBC-B
MEIS1
HM1 HM2
HM1 HM2
CTD
PREP1 HM1 HM2
Fig. 5 Structure of TALE homeodomain proteins. Pbxl is a member of PBC proteins while 
Meisl and Prepl are members of MEINOX proteins. a,b refer to splice variants of Pbxl and 
Meisl proteins. PBC-A, B, HM-1, 2 domains are shown. HD is the homeodomain, CTD the C- 
terminal domain and HCM is the fourth a-helix domain [90].
2.2 Prepl
Prep 1 is a m em ber o f  the M EINOX class o f  hom eodom ain transcription factors. It was 
identified as a com ponent o f  the human transcription factor UEF3, important for the 
regulation o f  the urokynase-type Plasm inogen A ctivator (uPA) enhancer [7]. The human 
Prepl gene (PK N O X 1) is located on chrom osom e 21 and encodes a 436 amino acids 
protein, while the m urine gene is on chrom osom e 17 and codes for a 435 am ino acids 
protein that shares 97%  identity with its human counterpart [8]. P rep l has a high degree 
o f  sim ilarity w ith the M einox protein M eisl, especially in the DNA recognition helix
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and, like Meisl, it shows a binding preference, but low affinity, for TGACAG and 
TGATNNAT elements [10]. Prepl and the PBC class proteins Pbx 1/2 associate through 
their N-terminal sequence and, thus, the dimer acquires a higher affinity for DNA and 
enhancing Hox dependent transactivation. Indeed Prepl, Pbx and HoxBl can form a 
transcriptionally active ternary complex on DNA (Fig. 6; [9]). Prepl, like Meisl, binds 
Pbx in a DNA-independent way forming dimeric DNA-binding factors [17,67].
Trans-activation:
HOXB1
b1-ARE R3
HOXB1
b1-ARE R3
Fig. 6 Prep/Pbx/Hox transactivation. Schematic representation o f the Prep/Pbx/Hox 
interaction: (top) Prep and Pbx alone cannot transactivate the bl-ARE enhancer R3 site o f the 
Hox gene; (middle) Pbx and HoxBl can activate transcription; (bottom) Prepl/Pbx/HoxBl 
complex determine the strongest transactivation [9].
Prepl is ubiquitously expressed in embryonic and adult mouse tissue, that is particularly 
strong in the thymus and testes, and is uniformly expressed during embryogenesis from 
the fertilized oocyte to 17.5 d.p.c. [36]. Prepl lacks a nuclear localization signal (NLS), 
but can translocate to the nucleus when it heterodimerizes with Pbx. Pbx is localized in
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the nucleus but, as shown in Drosophila Schneider cells, is exported to the cytoplasm. 
When Prepl/Pbx are complexed in the nucleus Pbx is no longer exported in the 
cytoplasm because Prepl (or Meis) inhibits this process (Fig. 7, [6]). It is also interesting 
that Prepl controls the level of Pbx, protecting it from degradation by favoring its entry 
into the nucleus. In fact excess Prepl increases the cellular level of Pbx and 
consequently the DNA binding activity of the Prepl/Pbx complex. Therefore, the 
balance between Prepl and Pbx and the rate of synthesis of Prepl is functionally 
important in determining the Pbx nuclear localization and activity [74]. This observation 
was also made in Drosophila and Zebrafish were Hth or Meis overexpression stabilize 
Exd and Pbx [70,129].
CYTOPLASM
PBX1/EXD
NES ->■
PBX1/EXD
NUCLEUS
£ I
EXPORT
RECEPTOR
PREP1/MEIS/HTH
Fig. 7 Prep/Pbx localization. Schematic representation o f the regulation o f the subcellular 
localization o f Pbx/Exd with or without Prepl/Meis/Hth in Drosophila Shneider cells. NES, 
Nuclear Export Signal; NLS, Nuclear Localization Signal [6].
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Prepl KO mice, like the Pbx and Meis KO mice, show an embryonic lethal phenotype 
[3,26,50,63,80,118]. In particular, Prepl embryos die at 7.5 d.p.c. [33]. An hypomorphic 
mutation (Prepl*71), which determines the expression of only 3-10% of the protein, is 
lethal in 75% of the embryos between E l7.5 and P0. 25% of the embryos survive, but 
have anomalies in T-cell development [100]. Prepl1/1 embryos show organ hypoplasia, 
eye malformation and anomalies in erythropoiesis and angiogenesis [37]. Prepl can also 
regulate the apoptotic potential of the cell, acting at the level of the Bcl-XL promoter. In 
fact Prepl171 Mouse Embryonic Fibroblast (MEF) show increased apoptosis [86]. 
However, Prepl overexpressing cells also show a high degree of p53-dependent 
apoptosis, since p53 is a direct transcriptional target of Prepl. In human, since Prepl is 
located on chromosome 21, it is overexpressed in Down Syndrome patient cells (as the 
cause of this disease is the presence of three copies of chromosome 21). In this case the 
increase in apoptosis maybe is responsible for the neurodegenerative phenotype and for 
immune defects [87].
Recently, it has been demonstrated that Prepl is a tumor suppressor since it is down- 
regulated in 70% of human tumors and since Prepl171 mice develop spontaneous tumors 
[75].
2.2.1 Prepl cooperates with other transcription factors
Prepl, in complex with Pbx, regulates the activity of a variety of proteins, such as: Pdx, 
Pax6, Octl, MyoD and Smad 2,3,4:
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> Pdx is an orphan homeodomain protein that regulates somatostatin. When Prepl 
associates with the Pdx/Pbx heterodimer increases the activation of the 
somatostatin promoter [42].
> Pax6 is an homeodomain protein fundamental for pancreas organogenesis. In 
non-pancreatic cells Prep/Pbx heterodimers can bind a G3B region on the 
glucagon gene enhancer and repress its transcription, while in pancreatic islets 
Pax6 can bind to the enhancer with its homeodomain, thus inhibiting the binding 
of the dimer and favoring glucagon expression [49].
> Octl is a POU homeodomain protein that is fundamental for the transcription of 
the gonadotropin releasing hormone (GnRH). The Prep/Pbx heterodimer can 
bind the regulatory region of the GnRH gene and, together with Octl, is essential 
for gene expression in hypothalamic neurons [109].
> MyoD is part of the bHLH proteins and is involved in myogenin expression. 
MyoD together with E2a binds DNA and regulates gene expression. The binding 
of a Pbx/Meis-Prepl dimer predisposes several muscle-specific genes to the 
transcriptional activity of MyoD-E2a [65].
> Smad proteins bind the responsive elements of Activin and activate transcription 
of the Follicle-Stimulating Hormone (FSH) gene. Pbx/Prep can form a complex 
with Smad proteins modulating Activin function [4].
2.2.2 Prepl inter actors
In addition to Pbx and Smad proteins, another direct interactor of Prepl has been 
recognized: 4EHP (eukaryotic translation initiation factor 4E homolog protein). 4EHP
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can heterodimerize with Prepl in the cytosol and regulate HoxB4 mRNA translation; 
this interaction is important for mammalian female germ cells development [128].
Thus only a few direct Prepl interactors are known. In order to find new Prepl 
interactors, a Tandem Affinity Purification (TAP) protocol was developed in our 
laboratory. TAP allowed us to identify macromolecular complexes under native 
conditions [23]. For this experiment a Prep-TAP construct was prepared and shown to 
be fully active in vivo: in the presence of Pbxl, Prepl-TAP was transported into the 
nucleus of the cell, indicating that Prep-TAP interacts with Pbx. Prepl-TAP was 
transcriptionally active and the TAP-tag did not interfere with DNA binding. This 
allowed to use two consecutive non-denaturing affinity purification steps [106,111], 
resolve the eluates by SDS-PAGE, and analyze them by MALDI-TOF Mass 
Spectrometry. In two independent experiments, as expected, Pbx lb and Pbx2 were 
found as specific interactors thus providing an internal control for the experiment. 
However, a new interactor was also identified (Fig. 8): the nucleolar protein p i60 myb 
binding protein la (p i60, MYBBP1A), based on the sequences obtained from 9 and 8 
different peptides, purified only from the nuclear fraction. From the nuclear fraction also 
non-muscle myosin heavy chain II A (NMMHCIIA), an actin associated motor protein, 
and p-actin were isolated. The specificity of these interactions has been characterized 
elsewhere.
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Mock
-► NMHCmyosinll A 
Mybbpla(pl60)
MAEMKSPTKAEPATPAEAAQSDRHSLLEHSREFLDFFVYDIAKPDQETRLRATEKLLE
YLRTRPNDSEMKYALKRLITGLGVGREAATACYSLALAQLLQSFEDIPLCDILDQIQEK
YSLQAMNKAMMRPSLFANLFGVLALFQSGRLVKDKEALMKSVQLLKH SQ H PN H LQ G
QPIKALVDILSEVPESMFQEILPKVLKGNMKVILRSPKYIELFLLAKQRVPTKLESLMGS
VDLFSEDNiPSLVNILKVAANSVKKEHKLPNVALDLLRLALKESRFELFWKKVLEEGLL
KNPSWrSSYWICFRLLGASLPLLSEEQLQLVMRGDLIRHFGENMVlSKPQNLFKIIPEIS
TYVGTFLEGCQDDPKRQLTMWAFTTITNQGLPVMPTFWRVrRFLNAEALQSYVAW L
RDMFLQPDLNSLVDFSTANQKRAQDASLNVPERAVFRLRKW1IHRLVSLVDHLHLEKD
EAW EQIARFCLFHAFFKTKKATPQIPETKQ HFSFPLD D RNRGVFVSAFFSLLQTLSVK
F RQTPDI-AENGKPW TYRLVQLADMLLWNRNYTSVTSLTTQQRQAWDQMMSTLKE
LEARSSETRAIAFQHLLLLVGLHIFKSPAESCDVLGDIQTCIKKSMEQNPRRSRSRAKA
SQEPVW VEVM VEILLSLLAQPSNLM RQW RSVFQHICPHLTPRCLQLILAVDNWVTD
DADEKQLQFIGEDEDSDNEDNKNSESDMDSEDGEESEEEDRDKDVDPGFRQQLMEV
LKAGNALGGVDNEEEEELGDEAMMALDQNLASLFKEQKMRIQARNEEKNKLQKEKK
LRRDFQIRALDLIEVLVTKQPEHPLILELLEPLLNVIQHSMRSKGSTKQEQDLLHKTARI
FMFHLCRARRYCHEVGPCAEALHAQVERLVQQAGSQADASVALYYFNASLYLLFWL
KGNTNKRHQDGHKL H G A D T E D S B Q A A N aD lD F V T R V Y S A S L E SL L T K R NSSLTV
PMFLSLFSRYPVICKNLLPVLAQHVAGPSRPRHQAQACLMLQKTLSARELRVCFEDP
EWEQLITQLLGKATQTLQHGEAQSKGEHQKELSILELLNTLLRTVNHEKLSVDLTAPL
GVLQSKQQKLQQSLQQGNHSSGSHRLYDLYW QAM RMLGVQRPKSEKKNAKDIPSD
TQSPVSTKRKKKGFLPETKKRKKLKSEGTTPEKNAASQQDAVTEGAMPAATGKDQP
PSTGKKKRKRVKASTPSQVNGITGAKSPAPSNPTLSPSTPAKTPKLQKKKEKLSQVN
GATPVSPIEPESKKHHQEALSTKEVIRKSPHPQSALPKKRARLSLVSRSPSLLQSGVK
K RR V A SRRVQ TP
Fig. 8 Tandem Affinity Purification of the Prepl interactome. On the left is shown the silver 
stained gel after TAP. C, cytoplasmic fraction; N, nuclear fraction for both mock (untreated 
cells) and PreplTAP expressing cells; on the right o f the gel are indicated the proteins identified. 
The right panel shows pi 60 protein sequence with in bold the peptides identified; adapted from 
[23].
3. Cell-Cycle regulation
3.1 Cell-cycle
The cell-cycle is an ordered series o f  events leading to cell replication. During cell-cycle 
a cell duplicates its DNA content and subcellular organelles and divides into two, in 
general identical, daughter cells w ith a very regulated and organized process.
The cell-cycle is divided in the M -phase (m itosis), i.e. the process that determ ines cell 
division, and interphase that is the period between two consecutives mitotic divisions
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and allows the cell to grow and replicate its content. Interphase is subdivided (as shown 
in Fig. 9) in G l, S and G2 phases:
Gl (Gap 1), is the period from the end of the previous M-phase (mitosis) to the 
onset of DNA synthesis (S-phase, see below). This is a “growth phase” during 
which there is a high biosynthetic activity. In particular, various enzymes 
required for DNA replication in the following S-phase are synthesized (Lodish 
H. et al., 2008).
> S  (Synthesis phase), starts with DNA synthesis. At the beginning of the S-phase 
each chromosome is composed of one chromatid that is replicated by DNA 
polymerase; the two chromatids are then joined at centromere. During mitosis, a 
protein complex called kinetocore, fundamental for chromosomes segregation, is 
assembled on the centromere. The centrosome is another important structure for 
cell division. In fact it is an organelle that serves as main microtubules 
organizing center. It is composed of two orthogonally arranged centrioles 
surrounded by pericentriolar material, made up mainly of Tubulin and 
Pericentrin. During this phase, centrosomes are also duplicated [110,122]. RNA 
transcription and protein synthesis are very low during this phase, only histone 
production takes place [93].
> G2 (Gap 2), starts immediately after the S-phase and lasts until the cell enters 
mitosis. During this phase there is again a significant increase in protein 
synthesis, mainly focused to the production of microtubules that are required for 
the mitotic process.
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After G2, the cell enters in mitosis and following cell division each daughter cell begins 
the interphase o f  a new  cell-cycle. However, some cells in G l enter a resting state (GO 
phase): they stop dividing and become quiescent or senescent. During quiescence the 
cell stops proliferation for a short or long period o f  time, som etimes indefinitely. This 
state is com m on for cells that are fully differentiated (e.g. neurons). Senescence occurs 
in cells that have DNA dam age and are not able to repair it. A standard cell-cycle lasts 
approxim ately 24 hours but only one hour is dedicated to mitosis, the rest is the time that 
the cell needs to replicate its content.
Fig. 9 Cell-cycle. Diagram showing cell-cycle subdivision in G l (GO), S, G2, M with the 
related checkpoints: G l ,  G2 and Spindle Assem bly Checkpoint.
Resting
Spindle Assembly Checkpoint
Check for C hrom osom e 
attachm ent to spindle
G2 Checkpoint
Check for Cell size 
and DNA replication
G1 Checkpoint
Check for Cell 
Nutrients,Grow 
and DNA dam:
Resting 
sta te  (G o )
hi /i  /  size,
I  /  ts, ro th factors 
■ /  age
27
3.2 Mitosis
Mitosis is the process that determines the division of a cell into two daughter cells with 
identical DNA content. Mitosis is divided in six phases: prophase, prometaphase, 
metaphase, anaphase, telophase and cytokinesis (Alberts B., et al. 1994) (Fig. 10):
> Prophase
During prophase, chromatin starts to condense into chromosomes that were 
previously duplicated in the S-phase. Each duplicated chromosome consists of a pair 
of sister chromatids joined at the centromere. During this period, cytoskeletal 
microtubules disassemble and start to organize into the mitotic spindle. The spindle 
is a bipolar structure that radiates from the two centrosomes in the cytoplasm. The 
action of microtubules (polymers of a/p Tubulin that switch phases of 
polymerization and de-polymerization, a sort of “dynamic instability” [89]), is very 
important for spindle function. During prophase the nucleolus disappears.
> Prometaphase
This phase starts with nuclear envelope breakdown, spindle entering into the nuclear 
area and kinetocores that start to form. The function of the kinetocore is to allow the 
attachment of chromosomes to the spindle microtubules, monitoring the attachment 
during cell division and activating a signaling pathway (i.e. the Spindle Assembly 
Checkpoint, described below) to delay cell-cycle if defects are detected. Moreover, it 
helps to power the movement of chromosomes on the spindle. Kinetocores can be 
subdivided in two regions: the inner kinetocore, that assembles on a repetitive DNA 
sequence and it is mainly constituted by CENP proteins and the outer kinetocore, a 
protein complex that takes contacts with microtubules and is mainly composed by
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Ndc80 complex and SAC proteins [78]. Kinetocores attach to the microtubules of the 
spindle (kinetocore microtubules) and the non-kinetocore microtubules 
(microtubules not attached to kinetocores) search and attach to non-kinetocore 
microtubules of the opposite pole; in this way the spindle is completed.
> Metaphase
During metaphase, the two centrosomes migrate to the opposite poles of the cell. The 
kinetocore microtubules align the chromosomes in a plane along the middle of the 
spindle, equidistant from the two poles (metaphasic plate) and a tension between the 
chromosomes and the opposite spindle pole is generated by the growing and 
shrinkage of microtubules. In particular, each chromosome has to be attached to its 
kinetocore microtubule in order to proceed to the following phase. If there are 
unattached chromosomes, the respective kinetocore generates a signal that activates 
the SAC and blocks mitosis progression.
> Anaphase
Anaphase begins when the duplicated centromeres of each pair of sister chromatids 
separate and are pulled toward opposite poles due to the action of the spindle. At the 
end of anaphase a complete set of chromosomes has assembled at each pole of the 
cell.
> Telophase
When sister chromatids arrive to opposite poles, the kinetocore microtubules 
disappear and non-kinetocore microtubules increase their length, stretching the cell. 
At the same time a new nuclear envelope starts to form around each group of 
chromosomes, chromatin begins to unfold and the nucleoli reassemble.
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> Cytokinesis
The last step consists in the division o f  the cytoplasm  at the level o f  the previous 
m etaphasic plate. In this region a contractile ring o f actin and myosin filam ents starts 
to form that shrinks the cell and breaks it, giving rise to two daughter cells.
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Fig. 10 Mitotic phases. Schematic representation of the mitotic phases with indicated the main 
components (From: http://kvhs.nbed.nb.ca/gallant/biology/mitosis_phases.html).
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3.3 Cell-cycle regulation: the importance of Cyclin-dependent kinases -  cyclins 
complexes
3.3.1 Interphase regulation
Cell-cycle is a very well ordered and controlled process and it is based on the interaction 
between cyclin-dependent-kinases (CDK) and cyclins. CDK are serine-treonine kinases 
that phosphorylate specific targets when bound to cyclins. At the onset of the Gl-phase, 
in response to growth factors, the cell determines the expression of fundamental genes 
for Gl/S transition (c-myc, c-fos). These genes are mainly transcription factors that 
determine the expression of cyclins D. Cyclin D can then associate with and activate 
CDK4, 6. When the complex CDK4, 6 / cyclin D reaches a critical level, it 
phosphorylates Rb that releases E2F from its inhibition (Fig. 11). E2F is essential for the 
Gl/S transition; in fact, it determines the expression of genes involved in nucleotides 
metabolism and DNA synthesis and activates the transcription of cyclins E and A. 
Cyclin E can then associate with CDK2 in late Gl and helps in maintaining the 
phosphorylation state of Rb phosphorylated and also phosphorylates p27, a CDK 
inhibitor, that is subsequently ubiquitinated and degraded. The association of cyclins A 
and E with CDK2 contributes to the activation of the pre-replication complex. In late Gl 
cdc25, a phosphatase that removes a phosphate from CDK2 activating it, is also turned 
on. In this way, cell enter the S-phase and DNA replication begins. Phosphorylation of 
these initiation factors prevents the reassembly of the pre-replication complex until the 
cell passes through mitosis, assuring that replication from each origin occurs only once 
during a cell cycle.
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3.3.2 Mitosis regulation
Cyclin B is also produced in the late S-phase and cyclins A and B can then associate 
with cdc25 activated CDK1. Cyclin A/B -  CDK1 functions as a mitosis promoting 
factor (MPF) that is active until late anaphase when APC/C and Cdhl determine its 
polyubiquitination and degradation (Fig. 11). MPF is important in mitosis since it 
promotes condensins phosphorylation in prophase and can, thus, contribute to chromatin 
condensation. MPF also phosphorylates regulatory proteins associated to microtubules 
that are responsible for microtubules dynamics. It then phosphorylates proteins of the 
nuclear lamina and this determines the nuclear lamina de-polymerization in 
prometaphase and the breakage of the nuclear envelope. After the attachment of every 
spindle fiber to the centromere, cdc20 is released and associates with APC/C. APC/C -  
cdc20, known also as Anaphase Promoting Complex, determines the polyubiquitination 
and degradation of securin that releases separases. Separases are proteolytic enzymes 
that cleave the cohesion ring at the centromere. The forces exerted by the mitotic spindle 
apparatus then pull the released sister chromatids towards opposite spindle poles. Once 
chromosomes are correctly separated, the cdcl4 phosphatase is activated and de- 
phosphorylates and activates Cdhl determining the polyubiquitination and degradation 
of all B cyclins and consequently the inactivation of MPF. Cdhl de-phosphorylates all 
the complexes previously activated by phosphorylation and all these proteins go back to 
their interphase function, leading to de-condensation of chromosomes, formation of 
interphase microtubules (that can re-constitute the cytoskeleton) and reassembly of the 
nuclear envelope (Lodish H. et al., 2008).
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Fig. 11 Cell-Cycle regulation. Schematic representation o f the principal components 
determinant for cell-cycle progression. G l, S, G2 and M indicates the different cell-cycle phases.
3.3.3 Checkpoints
As already m entioned above, cell-cycle is a very well controlled process: each step has 
to follow a correct order and must be com pleted before the subsequent steps can be 
carried out. Checkpoints ensure that chrom osom es are intact and that each step has been 
completed. In case o f  dam age cells undergo cell-cycle arrest until the dam age is 
repaired. In the case it is not repaired, cells induce apoptosis. Checkpoints act by 
blocking the action o f  the follow ing CDK -  cyclin com plex through specific inhibitors. 
The main CDK inhibitors are p21, p i 6 and p27 [29,46]. The failure o f  a checkpoint 
results in chromosom e instability that is at the basis o f  pre-cancerous and cancerous
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lesions. In fact, a defect in DNA replication control can be responsible for chromosomal 
rearrangements (e.g. deletions, amplifications and traslocations). Moreover, cell 
transformation or chromosomal disorders may arise from defects in spindle monitoring, 
leading to mitotic non-disjunction and producing the loss or gain of chromosomes and 
the consequent change in cell ploidy [45,79].
There are three important checkpoints:
> interphase checkpoint (G2 checkpoint), recognizing unreplicated DNA in the S- 
phase and inhibiting MPF activation; it is mediated by ATR and Chkl;
> Spindle Assembly Checkpoint (SAC), prevents the entry into anaphase until every 
single kinetocore of every chromatid is properly associated with spindle 
microtubules [92]. It is mainly mediated by MAD2 (Mitotic Arrest Defective 2) 
that inhibits Cdc20 and, by consequence, its association and activation of APC/C 
that promotes anaphase entry. The SAC pathway is quite complex: CDK1 and 
BUB 1 phosphorylate cdc20 and induce the recruitment of the SAC complex. The 
closed form of MAD2 (C-MAD2) dimerizes with MAD1 (CMAD2-MAD1) and 
is recruited at unattached kinetocores. This dimer activates the binding of the 
open form of MAD2 (0-MAD2) to cdc20, inhibiting its binding to APC/C. Other 
proteins, like BUBR1, that contributes to chromosomes alignment, MSP1 that is 
required for kinetocore localization of MAD proteins and Aurora B that 
functions as a tension sensor, detecting and destabilizing faulty 
kinetocore/microtubules attachment (e.g. unreplicated chromosomes), are 
involved in this pathway.
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> DNA damage checkpoint (Gl and G2 checkpoint), sensing DNA damage (from 
chemicals, radiations...) and determining a block in the cell-cycle until the 
damage is repaired. At the Gl/S transition it prevents cells from copying a 
damaged DNA and at the G2/M transition prevents chromosomes segregation if 
they are not intact. It is mediated by Chkl/2 and ATM/ATR. After DNA 
damage, these proteins activate p53 by phosphorylation, that, in turn, induces the 
expression of p21 [28], GADD45 [60] and MDM2 [133]. In particular p21 has 
multiple functions: it inhibits CDK/cyclins D, E determining a block in the Gl/S 
transition. It can also inhibit CDK 1/cyclin B action, blocking the entry into 
mitosis and it can also bind PCNA that is part of the DNA polymerase complex 
involved in DNA replication and, by so doing, determines a block in S-phase.
> Unreplicated centrosomes: the lack of centrosomes replication arrests the 
completion of mitosis [131].
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AIM OF THE WORK
The aim of my thesis was to study the interaction between Prepl and its new partner 
p i60 and to elucidate p i60 function. The issues that I dealt with were:
a) the interaction between Prepl and p i60, trying to elucidate whether this 
interaction was direct, defining the interacting region and understanding the 
consequence of this interaction for Prepl function.
b) the mechanism that causes the translocation of p i60 from the nucleolus to the 
nucleoplasm. In fact p i60 is localized in the nucleolus while Prepl is found in 
the nucleus. Among the conditions analyzed that cause translocation of nucleolar 
proteins to the nucleoplasm was mitosis, a physiological state that causes the 
disruption of nucleoli and the release of its components in the nucleoplasm.
c) the function of p i60 during the cell-cycle through immunofluorescence studies 
and evaluating the effects of a lower amount of p i 60 on mitosis progression.
d) a putative role of p i60 in neoplastic transformation, since this last aspect is 
frequently connected with abnormal cell-cycle progression.
e) to connect all the observations made on p i60 with its interaction with Prepl, 
since they share a similar phenotype.
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MATERIAL AND METHODS
1. Cell Culture and treatments
1.1 Cell culture
NIH 3T3, HeLa, F9, NT2-D1 and Phoenix cells were grown at 37°C, 5% CO2 in 
Dulbecco’s modified Eagle’s medium (DMEM, Gibco) supplemented with 10% heat- 
inactivated fetal bovine serum (FBS, Euroclone), 0.2 mg/ml streptomycin (Gibco), 20 
U/ml penicillin (Gibco), 2 mM glutamine (Gibco) and 1 mM sodium pyruvate (Gibco). 
HEK 293T were grown in Iscove’s Modified Dulbecco’s medium (IMDM, Cambrex) 
supplemented with 10% FBS, 0.2 mg/ml streptomycin, 20 U/ml penicillin and 2 mM 
glutamine.
Prepl non-overexpressing or overexpressing F9 cells clones (A2 and 2A18, 
respectively) have been described previously [74].
1.2 Treatments
Differentiation of NT2-D1 cells was performed treating the cells with 10 pM Retinoic 
Acid (RA, Gibco) for 48 hours; treatment with dimethyl sulfoxide (DMSO) was used as 
control.
To induce stress in the cells the following treatments were done:
- Actinomycin D (ActD, Sigma), 0.2 pM, 1 hour
- Hydroxyurea (Sigma), 10 mM, 4 hours
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- a-amanitin (Sigma), 10 pg/ml, 4 hours
- UV irradiation, 20J/m2 (UVC 254 nm, UY Stratalinker™ 1800 Stratagene)
- Cyclohexemide (Sigma), 10 pg/ml, 4 hours
- Anysomycin (Sigma), 10 pg/ml, 4 hours
- Thapsigargin (Sigma), 2,5 pg/ml, 6 hours
- Tunicamycin (Sigma), 2,5 pg/ml, 6 hours
- Temperature stress: 4°C, 20 minutes; 32°C, 4 hours; 42°C, 4 hours; 45°C, 20 minutes
- Oxidative stress: H2O2 (12 volume, Amati) 100 pM, 2 hours or 300 pM, 2 hours; DTT 
(Boeringer-Mannheim) 100 pM, 2 hours or 300 pM, 2 hours
- Osmotic stress: medium with 60% of H2O, 2 hours; NaCl (VWR) 150 mM, 4 days
- Low serum stress: 2% FBS, 24 hours; 0,2% FBS, 24 hours
- MG132 (Sigma) 10 pM, 6 hours
To block cells at the Gl/S transition I used double-Thymidine block. I treated cells (NIH 
3T3 or HeLa) with 2 mM Thymidine (Sigma) for 18 hours (first block), followed by a 
release of 9 hours and a second pulse with 2 mM Thymidine for 17 hours (second 
block).
2. Plasmids used
The plasmids used are shown in Tab. I.
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Tab I. List o f the plasmids used
Plasmid Description
pSG5-Prepl Plasmid encoding Prepl [9],[10]
pSG5-Pbxla/b Plasmid encoding Pbxla/b [9],[10]
pSG5-HoxBl Plasmid encoding HoxBl [9],[10]
pADML-R3 Plasmid encoding HoxBl enhancer [9],[10]
pADML-R4 Plasmid encoding HoxB2 enhancer [9],[10]
pact-c-pl60 Flag
Plasmid encoding pi 60-Flag [124] (provided by TJ. Gonda, 
University o f Queensland Diamantina Institute, Australia)
pact-c-p67* Flag Plasmid encoding p67-Flag [124] (provided by TJ. Gonda)
pGEM3Z-pl60 Plasmid encoding p i60 (Addgene)
pGEM3Z-p67* and p67 
deletion constructs
Plasmid encoding p67 and p67 deleted forms (Addgene)
pRufneo-pl60 Flag
Retroviral plasmid encoding pi 60-Flag [124] (provided by 
TJ. Gonda)
pGEX2T-Prepl GST
Bacterial expression vector for Prepl-glutathione-S- 
transferase (GST) [10].
pBabe-Myc
Retroviral vector for Myc (provided by Bemardi R., Dibit- 
HSR, Italy)
pBabe-Ras
Retroviral vector for Ras-Vall2 (provided by Bemardi R., 
Dibit-HSR, Italy)
2.1 Preparation of Prepl-GST deletion and point mutants
Bacterial expression vectors for Prepl deletion mutants were PCR amplified from pSG5- 
Prepl. Fragments were cloned into pGEX-4Tl (Stratagene). The primers were F1-R4 for 
HR1, F4-R3 for HR2, F1-R3 for HR1 plus HR2, F1-R2 for HR1 plus HR2* and F5-R1 
for HD plus C-terminus. The sequences of the primers used are the following:
- FI (BamHI): 5’-CCGGGATCCATGATGGCTACACAG-3’
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- F2 (Xhol): 5 ’-CCGCTCGAGATGAACAGTGAAACTCTG-3 ’
- F4 (BamHI): 5’-CCGGGATCCACAACTTCTGCCAG-3’
- F5 (Hindlll): 5’-CCGCTCGAGGGCCAAGTGGTCACACAG-3’
- R1 (Notl): 5 ’ -TCGCGGCCGCTGCAGGGAGTCACTGTTCGC-3 ’
- R2 (EcoRI): 5 TCCGAATTCTTGGGGAGTGACGAC-3’
- R3 (EcoRI): 5’-TCCGAATTCTTCTGTTTTCAGACAAGC-3’
- R4 (EcoRI): 5’-TCCGAATTCGCCTTCAGAGCCCTG-3’
The HR1 domain point mutants L63A, L66A and L63/66A were generated using the 
QuickChange site-directed mutagenesis kit (Stratagene) following the manufacturer 
instructions. Listed here are the primers used for the mutagenesis:
- L63A(sense):
CAGGCCATTTATAGGCATCCAGCATTTCCATTATTAGCTTTGT TG 
L63A(antisense):
CAACAAAGCTAATAATGGAAATGCTGGATGCCTATAAAT GGCCTG
- L66A(sense):
GCCATTTATAGGCATCCACTATTTCCAGCATTAGCTTTGTTG
- L66A(antisense): 
CAACAAAGCTAATGCTGGAAATAGTGGATGCCTATAAATGGC
- L63/66A(sense): 
CAAGCAGGCCATTTATAGGCATCCAGCATTTCCAGCATTA 
GCTTTGTTG
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L63/66A(antisense):
CAACAAAGCTAATGCTGGAAATGCTGGATGCCTATAA 
ATGGCCTGCTTG 
All constructs were verified by sequencing.
3. Transient transfection
Cells were plated in 10-cm plates for 24 hours, transfected with 4 pg of plasmid DNA 
using FuGene 6 (Roche) following the manufacturer protocol.
3.1 Transient pl60 silencing in HeLa cells
2 X 105 cells/well were plated in triplicate in 6-well plates for 24 hours, transfected with 
siRNA or control oligonucleotides (High-GC, Medium-GC, Invitrogen) at a 
concentration of 40 nM, following the manufacturer protocol.
The sequences of the siRNAs are the following:
- siRNA 1: CCAGGCTGGTGAATGTGCTGAAGAT
- siRNA2: CCCTGCAGCTAATTCTGGATGTGCT
- siRNA3: GAGGTCCTCAAAGCCGACTTGAATA
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4. Generation of retroviruses/lentiviruses and infection of NIH
3T3 cells
4.1 Retroviral infection and selection of stable clones
Phoenix ecotropic packaging cells [64] were transfected with 10 pg of retroviral plasmid 
using the calcium phosphate protocol [99] and incubated overnight. Two days after the 
transfection NIH 3T3 cells were infected with the filtered viral supernatant and 
supplemented with 8 pg/ml of Polybrene (Sigma) for 4 hours at 37°C. 24 hours after the 
infection the specific antibiotics were added to the DMEM for the selection: Geneticin 
for pRufneo-p 160-Flag (1 mg/ml, Gibco), Puromycin for all pBabe constructs (2 pg/ml, 
Sigma) and Hygromycin for pBabe-Myc and -Ras (200 pg/ml, Invitrogen).
4.2 Lentiviral infection and selection of stable pl60 clones
HEK 293T cells were transfected with 3.5 pg ENV plasmid (VSV-G), 5 pg packaging 
plasmid (pMDLg/p RRE), 2.5 pg of pRSV-REV and 15 pg of the target plasmid 
(pLKO.l-puro, containing one of the five different shRNA target sequences, Sigma) 
following a calcium phosphate transfection protocol. The day after transfection the 
medium was replaced by fresh medium supplemented with 1 mM Sodium Butyrate 
(Sigma). After 30 hours, the viral supernatant was collected and used to infect NIH 3T3 
cells. The day after the infection 2 pg/ml of Puromycin was added to the medium for 
selection.
The shRNA target sequences are the following:
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- s h R N A l :
CCGGCCTGCCCTAGAGACTCCTATTCTCGAGAATAGGAGTCTCTAGGGCA
-shRNA2:
CCGGCCTGATGAAGTCCGTGCAATTCTCGAGAATTGCACGGACTTCATCA
- shRNA3:
CCGGCCGGAGTGTATTTGGTCATATCTCGAGATATGACCAAATACACTCC
- shRNA4:
CCGGCCCAATGATTCGGAGATGAAACTCGAGTTTCATCTCCGAATCATTG
- shRNA5:
CCGGCCAAGCGTAACAGCTCACTTACTCGAGTAAGTGAGCTGTTACGCTT
5. Protein extraction
5.1 Total protein extraction
Cells were washed with PBS IX and scraped with RIPA buffer (100 pi for a 10 cm dish; 
buffer composition: Tris-HCl 5 mM pH 8, NaCl 150 mM, SDS 0,1%, NP-40 1%, Na- 
deoxicolate 0,5%, Protease Inhibitor IX -  Complete, EDTA free, Roche). Cells were 
incubated on ice for 30 minutes and after centrifugation at 14,000 rpm for 15 minutes at 
4°C, protein concentration was detected with the Bradford reagent (Bio-Rad Protein 
Assay, Bio-Rad) and measured at 595 nm with Ultraspectrophotometer 2100pro.
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5.2 Cytoplasmic and Nuclear protein extraction
Cells were detached and washed with cold PBS IX. Buffer A (300 pi for a 10 cm dish; 
buffer composition: Hepes-KOH 10 mM pH 7.8, MgCl2 1.5 mM, KC1 10 mM, DTT 0.5 
mM -  not added if the extract was for immunoprecipitation, Protease Inhibitor IX) was 
added to the cell pellet and incubated on ice for 10 minutes. 10% Triton X-100 (Sigma) 
was added to the cells as 1/30th of the buffer A volume, and the suspension vortexed for 
30 seconds. Samples were centrifuged for 1 minute at 11,000 rpm at 4°C to pellet nuclei. 
To the supernatant, representing the cytoplasmic fraction, was added 0.11 volume of 
buffer B (Hepes-KOH 0.3 M pH 7.8, KC1 1.4 M, MgCl2 30 mM, protease inhibitor IX). 
The pellet, representing the nuclear fraction, was washed in buffer A and resuspended in 
buffer C (1/5 of the original volume; buffer composition: Hepes-KOH 20 mM pH 7.8, 
glycerol 25%, NaCl 0.42 M, MgCl2 1.5 mM, EDTA 0.2 mM, DTT 0.5 mM- not added if 
the extract was for immunoprecipitation, Protease Inhibitor IX). Protein concentration 
was detected with the Bradford reagent and measured at 595 nm with 
Ultraspectrophotometer 2100pro.
6. Western Blot analysis
Protein extracts were resuspended in loading buffer IX (Buffer 4X composition: Tris 
375 mM pH 6.8, glycerol 30%, bromofenol blu 0.5 mg/ml, p-mercaptoethanol 8%, SDS 
6%), heated for 5 minutes at 95°C and loaded on a 10% gradient sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (SDS-PAGE) [71]. Following SDS-PAGE, proteins 
were transferred to polyvinylidene difluoride membrane (PVDF, Millipore) as described
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[125], After the transfer, filters were blocked for 16 hours at 4°C with blocking solution 
(5% w/v non-fat dry milk diluted in PBS IX supplemented with 0.1% Tween 20 (PBS- 
T) and incubated with the primary antibodies (Table II) diluted in blocking solution at 
the indicated concentrations, at room temperature (RT). After 1 hour, filters were 
washed three times for 10 minutes at RT with PBS-T and incubated for 1 hour with a 
peroxydase-conjugated secondary anti-mouse (Amersham), anti-rabbit (Amersham) or 
anti-goat antiserum (Amersham), depending on the primary antibody used, at the final 
dilution of 1:5,000 in blocking solution. Membranes were washed three times for 10 
minutes in PBS-T and developed with Super Signal West Pico chemiluminescence 
substrate system (Pierce).
7. Immunoprecipitation
Nuclear protein extracts were adjusted to IBB buffer (Tris-HCl 10 mM pH 8, NP-40 
0.2%, NaCl 150 mM) and a preclearing was performed with protein G-sepharose beads 
(Roche) for 1 hour at 4°C. The clarified supernatants were incubated with 5 pg of the 
indicated antibodies and recovered on protein G-sepharose beads or on M2-anti-Flag 
affinity resin (Sigma) overnight at 4°C. The beads were rinsed several times with IBB 
buffer, resuspended twice in loading buffer IX, heated at 95°C and centrifuged at 10,000 
x g. The supernatant was loaded on a 10% gradient SDS-PAGE as described previously.
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8. In vitro transcription-translation
Proteins were in vitro synthesized using the TNT T7 Quick coupled transcription- 
translation system (Promega) from 1 pg of plasmid DNA and 2 pi of translation grade 
[ S] methionine (0.03 mCi, Amersham Bioscences). Protein synthesis was evaluated by 
SDS-PAGE and the gel was fixed with 10% Methanol, 10% Acetic acid and 5% 
glycerol, dried and exposed to Amersham films.
9. Pull-down assay
GST fusion proteins were purified from Escherichia Coli BL21 cells grown in Luria- 
Bertani broth (LB) at 37°C to an optical density at 600 nm of 1. Protein expression was 
induced with 0.1 mM isopropyl-P-D-thyogalactopyranoside (IPTG, Sigma) for three 
hours, as described [10]. The pellets were sonicated in PBS IX with Protease Inhibitor 
IX supplemented with 1% Triton X-100, centrifuged at 13,000 rpm for 15 minutes and 
the supernatants were collected. Lysates containing the GST proteins were incubated 
with glutathione (GST) -Sepharose beads (Amersham) for 30 minutes at 4°C.
For pull-down assay, 10 pg of in vitro translated proteins precleared with 20 pi of 
glutathione beads in 200 pi of NET-N buffer (Tris-HCl 10 mM pH 8, NaCl 150 mM, 
NP-40 0.2%, Protease Inhibitor IX) were incubated for 1 hour at 4°C with 1 to 3 pi of 
the GST protein previously bound to the beads. Beads were washed five times in NET-N 
buffer and eluted twice for 15 minutes at RT with 10 mM glutathione. The quantity of 
eluted GST fusion proteins was evaluated by digital densitometry (ImageQuant 5.2,
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Molecular Dynamics) of Coomassie stained gels. Non-specific binding to GST was 
subtracted and data were normalized to the input.
10. Luciferase assay
4 X 104 cells were plated in a 24-well plate and transiently transfected with 25 ng/well 
of pAMDL-R3Hoxbl, R4-Hoxb2 Luciferase or pSG5-Hoxbl vector; 50 ng of Pbxla or 
Prepl vector; 20 ng p-galactosidase (P-Gal) plasmid and 50 to 500 ng of pact-c- 
pl60Flag or pact-c-p67Flag vector, using Fugene 6. After 24 hours the cells were lysed 
with reporter lysis buffer (100X Mg, IX ONPG reagent and 0.1M Sodium Phosphate, 
pH 7.5) and the Luciferase activity was determined using the Promega Luciferase Kit 
(Promega) in a Mithras Luminometer (Berthold Technologies). The Luciferase data 
were normalized by p-Gal assays as described [13].
11. EMSA
Electrophoretic mobility shift assay (EMSA) with b2-PP2 and Spl oligonucleotides 
were done as described [7,10]. The sequence of oligonucleotide b2-PP2 (5’- 
GGAGCTGTCAGGGGGCTAAGATTGATCGCCTCA-3’) contains both the Prepl- 
Pbxl and the Pbx 1-HoxBl binding sites of the Hoxb2 R4 enhancer [34]. The sequence 
of the Spl-binding oligonucleotide is 5’-GATCCGATCGGGGCGGGGCGAT-3’ [37].
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12. RNA extraction
Cells were plated and transfected using lipofectamine (for HeLa experiments) and 
Fugene (for NIH experiments) as described above. Total RNA was extracted with an 
RNAeasy minikit (QIAGEN) and quantified by spectrophotometry (Nanodrop, Thermo 
Scientific).
13. Real-Time PCR
5 pg of total RNA were reverse transcribed using a Superscript First-Strand kit with 
random primers (Invitrogen) according to the manufacturer’s instructions. For 
quantitative Real-Time PCR, 5 ng of reverse-transcribed RNA was amplified in a light 
cycler instrument (Roche) using a Fast Start DNA mix SYBR Green I kit (Roche). The 
PCR conditions for HoxB2 mRNA were the following: first denaturation and DNA 
polymerase activation step, 95 °C for 10 minutes; second denaturation step, 95 °C for 15 
seconds; annealing step, 56°C for 6 seconds; extension step, 72°C for 20 seconds. For 
actin, the conditions were as follow: first denaturation and DNA polymerase activation 
step, 95°C for 10 minutes; second denaturation step, 95°C for 15 seconds; annealing 
step, 58°C for 6 seconds; extension step, 72°C for 20 seconds. The amount of HoxB2 
mRNA was normalized to actin mRNA. The sequences of the primers used are the 
following:
- HoxB2 FW: TCCTCCTTTCGAGCAAACCTTCC
- HoxB2 RW: AGTGGAATTCCTTCTCCAGTTCC
- Actin FW: GGCATCCTGACCCTGAAGT
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- Actin RW: CGGATGTCAACGTCACACTT
For the microarray validation, 20 ng of the reverse-transcribed RNA was amplified with 
a Light-Cycler 480 (Roche) using a Universal Probe Library Assay (Roche) and 
following the manufacturer instructions. The PCR conditions were as follow: pre­
incubation at 95°C for 5 minutes, 50 cycles of amplification (denaturation at 95 °C for 10 
seconds, annealing at 58°C for 15 seconds and extension at 72°C for 1 second), cooling 
at 40°C for 10 seconds. The amount of the different mRNAs was normalized to 
GAPDH mRNA.
The sequences of the primers used with the relative probes are the following:
- p i60, probe 10
L: AGCACCTTCTGCTCCTCGT 
R: ATGCAGGTCTGGATGTCACC
- CDKN1A, probe 32
L: TCACTGTCTTGTACCCTTGTGC 
R: GGGGTTTGGAGTGGTAGAAA 
-NFKB2, probe 10 
L: CACATGGGTGGAGGCTCT 
R: ACTGGTAGGGGCTGTAGGC
- GADD45B, probe 10
L: CATTGTCTCCTGGTCACGAA 
R: TAGGGGACCCACTGGTTGT
- JUN, probe 19
L: CCAAAGGATAGTGCGATGTTT
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R: CTGTCCCTCTCCACTGCAAC
- T0P2B, probe 66
L: TCCAAGAGATTCTTTGCTTAGGA 
R: CATCCTCTTCTTCTGAGAAATCAAA
- GAPDH, probe 60
L: AGCCACATCGCTCAGACAC 
R: GCCCAATACGACCAAATCC
14. Immunofluorescence and confocal microscopy analysis
Cells were grown on 13 mm glass coverslips (VWR international) for at least 24 hours. 
Cells were washed three times with PBS IX, fixed with paraformaldehyde solution (3% 
paraformaldehyde; 2% sucrose in PBS IX) for 10 minutes at RT and then washed again 
three times in PBS IX. Cells were then permeabilized with a 0.2% PBS-Triton X-100 
solution for 5 minutes at RT, washed 3 times in PBS IX and blocked with IX PBS-1% 
BSA for 30 minutes at RT. The primary antibodies were added in blocking solution at 
the concentrations indicated in Table II for 30 minutes at 37°C. Cells were washed 3 
times in PBS and incubated with the secondary antibodies (Alexa-488 and Alexa-546 
conjugated anti-mouse or anti-rabbit immunoglobulin, 1:1,000 final dilution) and 
incubated for 30 minutes at RT protected from light. Cells were washed again 3 times 
with PBS IX and incubated with 4’6-diamidino-2-phenylindole dihydrochloride (DAPI) 
nuclear staining (Fluka) previously resuspended in PBS IX (1:1,000 final dilution) for 3 
minutes at RT or Hoechst 33258 (same conditions, Sigma). Cells were washed 3 times
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in PBS IX and coverslips were mounted with Fluorescent Mounting Medium (Dako 
Cytomation). Images were obtained with a Leica DMIRE2 (Confocal System Leica TCS 
SP2) with a 63X objective. Incubations with matched mouse isotype IgGs, irrelevant 
rabbit IgGs or secondary antibodies were always negative.
14.1 ImmunoFISH
The first part of this technique is a regular immunofluorescence (see above). After the 
washing step following the incubation with the secondary antibodies, cells were fixed 
again in 4% paraformaldehyde - 0,1% Triton X-100 at 4°C for 30 minutes. Cells were 
then incubated for 30 minutes at RT with 100 mM Glycin (VWR) and washed once with 
PBS IX. FISH was performed with Telomere PNA FISH kit/Cy3 (DAKO) following the 
manufacturer instructions; PNA probe was labeled with Cy3.
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Table n . List o f antibodies used in Westem-blot (WB) and Immunofluorescence (IF)
ANTIBODY Source WB IF
Anti-Flag mono/polyclonal Sigma 1:1,000 1:500
Anti-pl60 rabbit polyclonal
Donated by Ishii S. (RIKEN, 
Japan)
1:100
Anti-pl60C rabbit polyclonal Zymed laboratories 1:250
Anti-human Prep 1 CH 12.2 
Mouse monoclonal
Homemade [37] 2 [ig/ml
Anti-Prep 1 rabbit polyclonal Homemade [9] 2 [ig/ml
Anti-Prep 1 (Meis4) mouse 
monoclonal
Upstate Biotechnology 1 [ig/ml
Anti-Prep 1 mouse monoclonal Santa Cruz Biotechnology 1:50
Anti-Pbx2 rabbit polyclonal Santa Cruz Biotechnology 2 [ig/ml
Anti-Pbxlb mouse monoclonal
Donated by Cleary M.L (Stanford 
University, USA)
2 pg/ml
Anti-Tubulin mouse monoclonal Sigma 1:2,000 1:300
Anti-Phospho Histone H3 rabbit 
polyclonal
Millipore 1 [ig/ml
CREST human monoclonal Homemade 1:50
Anti-Nucleolin mouse monoclonal Santa Cruz Biotechnology 1:100
Anti-Nucleophosmin mouse 
monoclonal
Invitrogen 1:50
Anti-active caspase 3 rabbit 
polyclonal
MBL 1 [ig/ml
Anti-caspase 9 mouse monoclonal MBL 1 [ig/ml
Anti-|3 actin goat polyclonal Santa Cruz Biotechnology 1 [ig/ml
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15. Proliferation assay
The measurement of proliferation in HeLa cells was performed plating 2 X 105 
cells/wells in a 6-well plate and transfecting them with lipofectamine the day after. At 
24, 48 and 72 hours after transfection the cells were detached and counted with a cell 
counter (Coulter Z l, Coulter Diagnostics).
15.1 Crystal Violet assay
3,000 cells/well were plated in a 12-wells plate and fixed at the following time points: 
TO (8 hours after plating) and at 2, 4, 6, 8, 10 days after. For fixation, cells were washed 
in PBS IX, fixed with 11% glutaraldehyde (Sigma) for 15 minutes at RT and washed 
again in PBS IX 3 times and allowed to dry at RT. Cells were stained with Crystal 
Violet solution (0,1% crystal violet -Sigma- in 20% Methanol, 80% dF^O) for 20 
minutes at RT. Cells were washed with dFkO and dried at RT. Stained and dried cells 
were solubilized with a solution of 10% Acetic Acid for 10 minutes at RT and analyzed 
with a Microplate Reader 680 (Bio-Rad) at 570 nm.
16. Flow-Citometry analysis
16.1 EdU/7AAD staining
For 5’ethynyl-2’-deoxyuridine (EdU) / 7-amino-actinomycin D (7-AAD) double 
staining, cells were grown and pulsed before the assay with 10 fiM EdU for 1 hour, 
harvested and processed with Click-iT EdU Flow Citometry Assay kit (Invitrogen)
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following the manufacturer protocol. Anti-EdU-Fluorescein-isothycyanate (FITC) was 
used to stain EdU positive cells and 7-AAD was used to stain DNA. Cells were analyzed 
with FACS CANTO or FACS Calibur (BD Immunocytometry). Results were displayed 
as bivariate distribution of EdU content versus DNA content. The percent of cells in the 
S-phase was calculated by gating EdU positive cells (cells with the higher fluorescence 
intensity in the FITC channel compared to an unstained control) using FCS Express V3 
(De Novo Software) or CellQuest program (BD).
16.2 Annexin V staining
Cells were harvested, washed with PBS IX and the dead and apoptotic cells were 
detected by Annexin V Phycoerythrin (PE) / 7-AAD staining using PE Annexin V 
Apoptosis Detection kit I (BD Pharmingen), following the manufacturer’s instructions. 
Cells were analyzed with FACS CANTO or Calibur (BD) and results were displayed as 
bivariate distribution of Annexin V positive cells versus 7-AAD positive cells. 
Percentage of early apoptotic cells was calculated by gating Annexin V positive cells 
using FCS Express V3 or CellQuest programs.
17. Time-Lapse microscopy
Cells were plated in a 6-wells plate (2 X 105 cell/well in triplicate), transfected as 
described above with siRNA or High-GC control and blocked at the Gl/S transition 
using a double thymidine block. Starting 8 hours after the release from the block and up 
to 24 hours later, the cells were analyzed with Time Lapse Microscope (OKO VISION).
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Images were taken in 4 different fields for each sample every 5 minutes with a 5X 
objective and analyzed with Image J software.
18. Karyotyping
Cytogenetic analysis of HeLa and NIH 3T3 cell lines after siRNA / shRNA treatment 
was performed according to standard methods: cell lines were incubated overnight with 
Colcemid (1 pl/ml, Invitrogen), trypsinized and washed with sterile PBS IX. Cells were 
then treated for 15 minutes with hypotonic solution (0.075 M KC1) at 37°C and then 
fixed with three passages in cold Camoy’s fixative (methanol: acetic acid, 3:1). 
Harvested samples were dropped on wet glass slides and chromosome QFQ banding was 
carried out using standard procedures. Metaphase spreads were analyzed by a 
fluorescence microscopy Nikon 90i and the Genikon software (Nikon Instruments 
Italia). The description of karyotypes and clonality criteria followed the International 
System for Human Cytogenetic Nomenclature recommendations (ISCN 2009). The 
karyotype analysis was made by Pecciarini L. at the Pathology Unit (Dibit, HSR, Milan 
-  Italy).
19. Gene Expression Profiling
For gene expression profiling, the RNA from three technical replicates of HeLa cells 
transfected with High-GC control or siRNA 1 was extracted, following the procedure 
described above. RNAs were analyzed with Affimetrix Human Gene 1.0 ST chip
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(Affimetrix). Biotin-labelled cDNA targets were synthesized starting from 100 ng of 
total RNA. Double stranded cDNA synthesis and related cRNA was obtained with 
GeneChip WT cDNA Synthesis and Amplification Kit (Ambion). With the same kit the 
cDNA sense strand was synthesized, then fragmented and labelled with GeneChip WT 
Teminal Labeling Kit (Ambion). DNA fragmentation was performed with a combination 
of uracil DNA glycosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE 1), 
while labeling was completed using terminal deoxynucleotidyl transferase (TdT) in the 
presence of GeneChip® DNA Labeling Reagent. All steps of the labelling protocol were 
performed as suggested by Affymetrix
(http://www.affVmetrix.com/support/technical/manual/expression manual.affxl. The
size (the range size of the fragmented sample should be approximately 40 to 70 nt) and 
the accuracy of quantification of targets were checked by agarose gel electrophoresis of 
2 pi aliquots of each sample after fragmentation. External controls (spikes) were used; 
each eukaryotic GeneChip® probe array contains probe sets for several B. subtilis genes 
that are absent in the samples analyzed (lys, phe, thr, and dap). This Poly-A RNA 
Control Kit contains in vitro synthesized, polyadenylated transcripts for these B. subtilis 
genes that are pre-mixed at staggered concentrations to assess the overall success of the 
assay. Samples were then hybridized as indicated by Affymetrix: diluted in 
hybridization buffer (100 mM MES, 1 M [Na+], 20 mM EDTA, 0.01% Tween 20) at a 
concentration of 25 ng/pl, denatured at 99 °C for 5 minutes and centrifuged at maximum 
speed for 1 minute prior to introduction into the GeneChip cartridge. A single GeneChip 
Human Gene 1.0 ST was then hybridized with each biotin-labelled sense target. 
Hybridizations were performed for 16 hours at 45 °C in a rotisserie oven. GeneChip
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cartridges were washed and stained with GeneChip Hybridization, Wash and Stain Kit in 
the Affymetrix fluidics station following the FS450 0007 standard protocol. Images 
were scanned using an Affymetrix GeneChip Scanner3000 7G with default parameters. 
The resulting images were analysed using GeneChip Operating Software vl.2 
(GCOS1.2). Raw data were first normalized using RMA method [12,54,55]. In order to 
evaluate the variability between samples, Principal Component Analysis (PCA) was 
performed. After this analysis an ANOVA test and a False Discovery Rate (FDR, 
[5,107] to exclude false positives) was applied and the resulting gene-list was refined 
with a p value < 0.05 and a fold change > 1.75. Gene ontology analyses of the 
differentially expressed genes were performed with the DAVID 6.7 functional 
annotation tool (Database for Annotation, Visualization and Integration Discovery -  
NIH, http://david.abcc.ncifcrf.gov/home.jsp) according to Huang et al. [52].
20. Soft-agar assay
Cells were resuspended in DMEM with 0.3% agar in a concentration of 5,000 cells/well 
and plated over a 0.6 % agar layer in a 6-wells plate. The experiment was performed in 
triplicate and plates were incubated at 37°C in an humidified incubator for two weeks. 
Colonies detection was performed staining the cells with 3-(4,5-dimethylthiazol-2-ye)- 
2,5-diphenyltetrazolium bromide (MTT, 1:10 in PBS IX) for at least 4 hours. After 
staining, the plate was scanned and the image obtained was analyzed with Image J 
Software.
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RESULTS
1. Biochemical and functional analysis of the Prepl-pl60MBP 
interaction
1.1 Prepl co-immunoprecipitates with pl60
Tandem Affinity Purification (TAP) followed by a MALDI-TOF/MS analysis was used 
to identify Prepl interactors that might be important for its phenotype. From this 
analysis, few proteins were isolated that specifically interacted with Prepl. Among this 
interactors p i60 myb binding protein la  (p i60) was identified by the sequence of 9 and 
8 different peptides in two independent experiments [23]. To demonstrate that the 
interaction was specific, I performed an immunoprecipitation using nuclear extracts 
from NIH 3T3 cells infected with p i 60-Flag or GFP as control. The 
immunoprecipitation was performed with an M2 anti-Flag affinity resin. As shown in 
Fig. 12, Prepl specifically co-immunoprecipitated with p i60, but not with GFP, while 
Pbxlb and Pbx2 did not immunoprecipitate with either p i60 or with GFP. As control, I 
immunoblotted with an anti-pl60 antibody: this recognized the protein only in the pi 60- 
Flag infected cells (not shown), p i 60-Flag overexpression did not affect the protein level 
of Prepl, Pbxlb or Pbx2 (Fig. 12, input panel on the right). This result shows that Prepl 
and p i60 are part of a stable complex in vivo that does not contain Pbx and suggests that 
p i60 might be a specific Prepl interactor.
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Fig. 12 Prepl and pl60 interact in vivo. Immunoprecipitation using M2 anti-flag resin and 
immunoblotting with the indicated antibodies o f nuclear extracts o f NIH 3T3 cells infected with 
a p i 60-Flag or GFP (as control) retrovirus. Input and immunoprecipitates (Ip) are compared.
1.2 P re p l and p l6 0  d irectly  in teract in vitro
To demonstrate that the interaction between Prepl and p i60 was direct I performed pull­
down assays. For this experiment full-length p i60 was in vitro translated and labeled 
with 35S. I tested also its shorter forms: p67 (which represents the N-terminal part, aa 1- 
580) and pl60C (the C-terminal of the protein, aa 580-1344) (Fig. 13A). Pbxlb was 
used as control (since it directly interacts with Prepl, [9]). As shown in Fig. 13B, 35S- 
pl60 binds GST-Prepl but not GST alone. 35S-p67 also gave a strong signal, while there 
was no signal with 35S-pl60C. As expected, 35S-Pbxlb strongly associated with GST-
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Prepl. Therefore this pull-down demonstrates that p i60 specifically interacts with 
Prepl, in particular its N-terminal part.
A
p l6 0
p67
p l60C
200 400 600
--T~
800 1000 1200
200 400 580
600 800 1000 1200
TD Input
10% GST Prepl
4 7 ,5 -
83 —
47.5—
35S-pl60
-35S-p67
•35S-P160C
-35S-Pbxlb
- GST-Prep 1 
•GST
Coomassie
Fig. 13 Prepl and p l60  in vitro interaction. (A) Schematic representation o f p i60 deletion 
mutants; the leucine zipper-like motifs (L), the acidic domain (A), and the basic carboxyl- 
terminal region (B) are indicated. (B) Pull-down assay o f GST-Prep 1 or GST alone as control,
with in vitro translated 35S-pl60, 35S-p67, 35S-pl60C and 35S-Pbxl. In the upper part o f the
figure the different pull-downs are shown and at the bottom, the Coomassie-stained gel o f GST 
and GST-Prep 1.
I also wanted to explore which Prepl domain interacted with p i60. I prepared Prepl 
deletion mutants as shown in Fig. 14A and performed pull-down assays with 35S-p67 
(shown above to interact with Prepl) and 35S-Pbxlb (which interacts with the N- 
terminal part of Prepl, [9]). As shown in Fig. 14B, 35S-p67 and 35S-Pbxlb strongly 
bound to HR1, HR2, HR1+HR2 and HR1+HR2* but not to the C-terminal part 
(HD+CT) of Prepl. Moreover, full length 35S-p 160 associated with HR1 (Fig. 14C). The 
data show that both p i 60 and Pbx bind the HR1 domain of Prepl. However, 35S-p67 and 
35S-Pbxlb have also a low binding activity with HR2.
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Fig. 14 Identification o f the Prepl domains required for p l60  binding. (A) Schematic 
representation o f the Prepl mutants and quantification o f the binding with 35S-p67 (average of 
three determinations; HR1+HR2* was given the arbitrary value o f 100%). (B) Representative 
pull-downs o f the in vitro translated 35S-p67 (left) and 35S-Pbxlb (right) with the different GST- 
Prep 1 deletion mutants. (C) Representative pull-down o f 35S-pl60 with GST-HR1. On the top 
are shown the autoradiographies and on the bottom the Coomassie staining o f the gels.
1.3 Identification of the pl60 binding site on P rep l
To identify the binding site of p i 60 on Prepl, I analyzed the HR1 sequence and noticed 
the region 63LFPLLALL70 conserved in all mammalian MEINOX proteins (Fig. 15A). 
This sequence is composed of 2 overlapping LXXLL motifs. Interestingly, this motif is 
present also in other pi 60-binding proteins (e.g. in PGCla there are 2 LXXLL motifs 
starting at aa 147 and 210, respectively) [30,124]. I produced HR1 mutants inserting 
point mutations in L63 and L66 (substituting leucine with alanine) and performed pull-
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down assays of the GST-HR1 mutants with the in vitro translated 35S-p67 and 35S- 
Pbxlb. As shown in Fig. 15B and C, the relative binding of 35S-p67 and 35S-Pbxlb to 
HR1 was decreased in both L63A and L66A mutants and was almost absent when both 
mutations were present at the same time (HR1 L63/66A). The relative binding of full- 
length (L63/66A) GST-Prepl to both 35S-p67 and 35S-Pbxlb was also diminished (Fig. 
15D). Therefore p i60 and Pbx bind the same region in the HR1 domain of Prepl. 
Another interesting observation is that L63A mutation alone gives a reduction of the 
binding of 53% and L66A of 72%, indicating that also the second LXXLL motif is 
important for the binding.
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Fig. 15 The LFPLLALL sequence o f the HR1 domain is required for the interaction with 
both p67 and Pbxl. (A) Alignment o f murine Prepl HR1 domains with its murine Meinox 
homologs, highlighting the conserved leucine-rich region (shaded). The asterisks indicate the 
conserved amino acids. (B) Representative pull-downs o f in vitro translated 35S-p67 or 35S- 
Pbxlb  with wild-type (WT) and mutant (L63A, L66A, L63/66A) GST-HR1 and GST alone as 
control. At the top is shown the autoradiography and at the bottom the Coomassie staining o f the 
gel. (C) Quantification o f the binding after densitometric analysis o f the pull-downs 
autoradiographies (mean o f three experiments). The error bars indicate standard deviations. (D) 
Representative pull-down of 35S-p67 and 35S-Pbxlb with GST-Prepl and GST-Prepl L63/L66 
mutant. On the top is shown the autoradiography and on the bottom the Coomassie staining of 
the gel.
1.4 Identification of the P repl binding region in pl60
I also analyzed the p i60 region involved in the binding to Prepl preparing p67 deletion 
mutants, since this is the region involved in the binding. As described in the
GST-Prepl
Coomassie
35S-p67
35S-Pbxla
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Introduction, p i60 contains leucine-rich motifs (one leucine-zipper-like domain and 
several leucine-charged-domains -  LCD) in its N-terminal region, which may be 
necessary for protein-protein interaction and hence could be important for Prepl binding 
(Fig. 16A). Pull-down assays of the in vitro translated 35S-p67 deletion mutants and 
GST-HR1, or GST alone as control, showed that the deletion of the C-terminal part up to 
residue 228 did not significantly affect the binding (Fig. 16). Therefore the leucine- 
zipper-like domain located in this region (starting at aa 307) is not important for Prepl 
binding: the same was observed for c-Myb [124]. However, further deletion from 
residue 113 to 228 (p i2) almost abolished binding. Moreover, the N-terminal deletion 
up to residue 51 did not affect the binding. However, the 51-151 deletion greatly 
decreased the binding. I conclude that the p i60 region from amino acid 113 to 151 is 
extremely relevant for Prepl binding. As shown in Fig. 4 (Introduction), this region 
contains LCD motifs and LXXL motifs starting at residues 94, 135, 160 and 245 (Fig. 
16A), all sequences that can mediate protein-protein interactions.
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Fig. 16 The region between amino acids 51 and 151 of pl60 participates in the binding to 
Prepl. (A) Schematic representation o f the p67 deletion mutants with highlighted the leucine- 
rich sequences and the leucine zipper domain (L). On the right is shown the quantification by 
densitometric analysis o f the relative binding o f each mutant to GST-HR1 (average o f three 
different experiments); wild-type p67 was given the arbitrary value o f 100%. (B) Representative
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pull-down o f GST-HR1 with the in vitro translated S-p67 deletion mutants; on the left is 
shown the input, on the right the pull-down and in the bottom part the Coomassie staining o f the 
gel.
1.5 p l6 0  com petes w ith  P bx for th e binding to P rep l and inhibits its transcriptional 
activ ity
Since p i60 and Pbx bind the same region on Prepl, they must compete for the binding. 
Thus, p i60 should interfere with Pbxl transcriptional activity. To test this hypothesis I 
performed a pull-down assay of GST-Prepl and GST-HR1 with in v/Tro-translated 35S- 
p67 and 35S-Pbxlb, separately and together. As shown in Fig. 17A, in the presence of 
p67, the amount of Pbxlb bound to Prepl was decreased. This suggests that p i60 
competes with Pbx for binding Prepl.
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I also investigated  a possib le inhibition o f  the P b x l dependent transcriptional activity . I
transiently  transfected  N IH  3T3 cells, stably expressing  p i 60 or G FP (as control), w ith  a
luciferase reporter driven by the H o x B l enhancer. A s already described, a high
luciferase activ ity  is induced only in the presence o f  the th ree proteins: P rep l, P b x l and
H o x B l [9,34,35,56]. H ow ever, w hen p i 60 w as present, the luciferase activity  w as
alm ost absen t (Fig. 17B).
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Fig. 17 pl60 competes with Pbx in the binding to Prepl and inhibits its transcriptional 
activity. (A) Competitive pull-down assay o f 35S-p67 and 5S-Pbxla with GST-Prepl or GST- 
HR1 beads. On top is shown the autoradiography, at the bottom the Coomassie staining o f the 
gel. The proteins used in each reaction are indicated on the top o f the figure. (B) Transient 
transfection o f a Luciferase reporter plasmid (pADML-R3), containing the R3 sequence o f the 
HoxBl enhancer into NIH 3T3 cells stably expressing p i 60 (white) or GFP (black) with the 
indicated expression plasmids. The activity (RLU/J3-Gal) was measured 24 h after transfection 
and the value was divided by the expression o f the internal transfection control (3-Gal. The 
histogram represents the average o f three independent experiments performed in triplicate; **, 
P< 0.001, t test.
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Using EMSA, I also tested the inhibition of Prepl DNA binding activity by p i 6 0 .1 used 
NT2-D1 cells, a teracarcinoma cell line that can be induced to differentiate and to 
transcribe HoxB genes with retinoic acid (RA) [35]. Nuclear extracts of cells stably 
expressing p i60, or empty vector as control, were tested for DNA binding capacity to an 
oligonucleotide specific for Prepl-Pbxl dimer and Prepl-Pbxl-HoxBl trimer [34]. p i 60 
overexpression decreased the intensity of the shifted bands (corresponding to the 
Prepl/Pbxl and Prepl/Pbx 1/Hoxbl complexes) in untreated and even more in RA 
treated cells (Fig. 18A). However p i 60 did not change the DNA-binding activity of the 
control transcription factor Spl.
The significance of this inhibition was checked by Real-Time PCR measuring the level 
of HoxB2 mRNA in NT2-D1 cells after addition of RA. Induction of HoxB2 mRNA 
was reduced by 45% in p i60 overexpressing compared to control cells (Fig. 18B).
All these experiments demonstrate that p i60 competes with Pbx in the binding to Prepl 
and this interaction inhibits the transcriptional activity in which Prepl and Pbxl are 
involved.
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Fig. 18 p l60 inhibits Prepl DNA-binding activity. (A) EMSA assay with nuclear extracts of 
NT2-D1 control or p i 60 overexpressing cells, treated/untreated with RA for 48h and incubated
with P-b2-PP2 oligonucleotide [34]. Below is a control EMSA performed with an 
oligonucleotide containing the sequence for the Spl transcription factor. In the bottom part is 
shown an immunoblot (IB) with anti-Flag for p i60, anti-Prep 1 and anti-actin as loading controls. 
(B) Real-Time PCR measurement o f Hoxb2 mRNA level in NT2-D1 cells expressing p i60 or 
control vector and treated or not with RA. Data from two independent experiments performed in 
triplicate.
1.6 p l6 0  interacts w ith  P re p l in the nucleus
p i60 is a nucleolar protein [62,124]. I studied its subcellular localization by confocal 
microscopy in NIH 3T3 cells. As shown in Fig. 19A, p i60 staining indicates that it is 
localized mainly in the nucleolus and this was confirmed by a co-staining with anti- 
Nucleolin, a known nucleolar protein antibody (data not shown). I also analyzed the p67 
form that was absent in nucleoli, since it lacks the nucleolar localization signal, but 
mostly present in the nucleoplasm [124] (Fig. 19B). Less than 5% of the cells analyzed
Prepl.Pbx t/Hoxbl 
Prep I.Pbxl
IB:
a-Flag
a-Prepl
a-actin
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also showed a nuclear staining with the full-length protein, suggesting that it can shuttle 
between nucleolus and nucleoplasm.
Since Prepl acts mostly (if not exclusively) at RNA polymerase II-dependent promoters, 
I expected that a functional interaction between the two proteins would take place in the 
nucleoplasm. A physiological condition that induces the translocation of nucleolar 
proteins to nucleoplasm is mitosis. During mitosis, nucleoli disassemble at the stage of 
prophase (when transcription shuts down) and reassemble around the rDNA genes when 
cell division is completed [11]. I therefore analyzed p i60 and Prepl localization in NIH 
3T3 cells during mitosis by confocal microscopy. As shown in Fig. 19C, 
immunofluorescence fails to show co-localization between the two proteins in 
interphase, since Prepl is present in the nucleus and p i60 in the nucleolus. During 
mitosis, p i60 assumed a peculiar localization in a para-chromosomal area (see also later 
pictures), while Prepl staining is more diffuse. Therefore there does not seem to be a 
significant co-localization during mitosis.
Then I tried to induce the translocation of p i 60 to nucleoplasm with different treatments: 
drugs that cause the inhibition of RNA-polymerase II transcription (hydroxyurea, a- 
amanitin, UV, cyclohexemide, anysomycin and actinomycin D), reticulum endoplasmic 
stress (thapsigargin, tunicamycin), temperature stress (4°C, 32°C, 42°C, 45°C), oxidative 
stress (H2O2, DTT), osmotic stress (H2O, NaCl), low serum (2%, 0,2%) and proteasome 
inhibition with MG 132 (Fig. 20A). Among these stresses, only Actinomycin D (ActD), 
an inhibitor of RNA polymerase I and of DNA replication [116,120], determined p i60 
translocation. After the treatment with 0.2 pM ActD for 1 hour a complete translocation 
of p i60 to the nucleoplasm was visible and the effect was reversible (Fig. 20B). I
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perform ed the same experim ent by staining the cells for both Prepl and p i 60. In 
physiological conditions the two proteins did not co-localize, as expected. However, 
after treatm ent with ActD there was a significant increase in the nucleoplasm ic co­
localization (Fig. 20C).
These experiments dem onstrate that p i 60 can shuttle between nucleoli and the 
nucleoplasm  and co-localizes with P repl only under conditions that inhibit the nucleolar 
function.
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Fig. 19 Immunofluorescence study of p i60 and Prepl localization. (A) Confocal microscopy 
o f NIH 3T3 cells after staining with anti-pl60C antibody (left) and Hoechst 33258 for nuclei 
(right). The arrow shows a cell with both nuclear and nucleolar staining; most cells showed 
nucleolar staining only. (B) Confocal microscopy of NIH 3T3 cells transiently transfected with 
p67-Flag, after staining with anti-Flag (left) and Hoechst 33258 for nuclei (right); no nucleoli 
were positive for p67. (C) Confocal microscopy of NIH 3T3 cells stably transfected with pi 60- 
Flag and stained with anti-Flag (green), anti-Prep 1 (red) and DAPI (blue) in interphase (upper 
part) or metaphase (bottom).
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Hydroxyurea, 10 mM, 4 h 45‘C, 20 min
a-amanitin, 10 pg/ml, 4 h H202 100 pM, 2 h
UV, 20 J/m2 H202 300 pM, 2 h
Cyclohexemide, 10 pg/ml, 4 h DTT 100 pM, 2 h
Anysomycin, 10 pg/ml, 4 h DTT 300 pM, 2 h
Actinomycin D, 0,2pM, 1 h Medium with 60% H20, 2 h
THAPSIGARGIN 2,5 pg/ml, 6 h NaCI, 150 mM, 4 days
TUNICAMYCIN 2,5 pg/ml, 6 h 2% serum , 24 h
4 gC, 20 min 0,2%  serum , 24 h
32°C, 4 h MG132, 10 pM, 6 h
42°C, 4 h
B
c r a y
CTL ActD
Fig. 20 ActD induces p i60 translocation. (A) Summary of the stress stimuli used. (B) 
Confocal microscopy o f NIH 3T3 cells, control or treated with 0,2 p.M ActD for 1 h. ActD+24 
FBS refers to cells treated with ActD as above, washed and left in complete DMEM for 24 h. 
Staining is with anti-pl60C. (C) Confocal microscopy of NIH 3T3 cells, control or treated with 
0,2 |iM ActD for 1 h, stained with anti-pl60C, anti-Prep 1 and Hoescht 33258 for nuclei.
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Since p i60 and Prepl co-localize after ActD treatment, this was the best condition to 
demonstrate the co-immunoprecipitation of the endogenous proteins. To perform this 
experiment I used F9 teratocarcinoma cells line since NIH 3T3 cells express very low 
level of Prepl while NT2-D1 cells do not contain endogenous p i60. F9 cells express 
good level of both proteins and can be also induced to express HoxB genes with RA 
[74,98]. After ActD treatment, F9 cells immunofluorescence showed the translocation of 
p i60 in the nucleoplasm where it co-localized with Prepl (Fig. 21 A). ActD treatment 
induced also the co-immunoprecipitation of the two endogenous proteins (Fig. 2 IB). 
Thus, p i60 and Prepl co-localize and co-immunoprecipitate in the nucleoplasm after 
ActD treatment, while during mitosis it is still not clear. It is very interesting to notice 
that in untreated F9 cells a certain level of Prepl is present also in nucleoli, as suggested 
by co-localization of the two proteins (Fig. 21 A).
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Fig. 21 Endogenous pi 60 and Prepl co-localize in the nucleoplasm and co- 
immunoprecipitate after ActD treatment. (A) Confocal microscopy of F9 cells, control or 
treated with ActD 0,2 pM for 1 h; the staining was performed with anti-pl60C, anti-Prepl and 
DAPI for nuclei. (B) Co-immunoprecipitation o f Prepl and pl60 from nuclear extract of F9 cell 
treated (+) or not (-) with ActD. The immunoprecipitation was performed with anti-Prepl 
monoclonal antibody or control IgG and the immunoblot (IB) with anti-Prepl and anti-pl60C.
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Summary of Results 1
In this first section I have shown that p i60 is a new direct Prepl interactor, p i60 binds 
Prepl at the level of HR1, in a leucine-rich region through its N-terminal part, the same 
binding region of Pbx. This indicates a competition between the two proteins in the 
binding to Prepl and highlights the role of pi 60 as a Prepl inhibitor, since, without Pbx, 
Prepl cannot exert its transcriptional activity. I demonstrated also that Prepl and p i60 
mostly interact in the nucleoplasm, even if the main p i60 localization is in the nucleoli. 
However, the possibility that a minor fraction of Prepl is localized in the nucleolus and 
can interact there with p i60 or that only the small amount of p i60 present in the 
nucleoplasm mediate this interaction cannot be excluded by my experiments. In fact, in 
one cell line (F9 cells), immunofluorescence shows that a portion of Prepl is localized in 
the nucleolus.
The data presented in this section have been published in: Diaz V.M., Mori S.. 
Longobardi E., Menendez G., Ferrai C., Keough R.A., Bachi A. and Blasi F. “pl60 
Myb-binding protein interacts with Prepl and inhibits its transcriptional activity.” Mol. 
Cell. Biol. 27(22), 7981-7990 (2007) [24].
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2. Cell-cycle defects in p!60-depleted cells
2.1 The nucleolar protein pl60 distributes in a para-chromosomal region during 
mitosis
As already shown by immunofluorescence, p i60 is localized in the nucleoli during 
interphase. Since nucleoli are disrupted at the beginning of mitosis, nucleolar proteins 
relocate from the nucleolus to other structures [11]. In particular, I observed a peculiar 
re-localization of pi 60 around the metaphasic plate (Fig. 22). I studied p i60 localization 
during mitosis in detail by immunofluorescence confocal microscopy on NIH 3T3 cells, 
stably expressing pi 60-Flag synchronized by a double Thymidine block to enrich the 
mitotic population. I used this cell line because of the lack of a good antibody against 
p i60 to use for immunofluorescence. Moreover, in this cell line the level of p i60 was 
not higher than in the wild-type NIH 3T3 cell line (data not shown). As shown in Fig. 
22, p i60 localization varies within the cell-cycle: in prophase p i60 is located on the 
condensed chromosomes, partly co-localizing with Tubulin, a major constituent of 
microtubules, essential for the constitution of the mitotic spindle. In metaphase and 
anaphase, p i60 is located at the periphery of the metaphasic plate and, in particular, it 
accumulates in two regions on the side of the plate, separated from Tubulin. During 
telophase, p i60 starts to re-populate the two daughter cells as pre-nucleolus-like foci and 
then, as soon as mitosis is completed, p i60 redistributes in the newly formed nucleoli.
I then performed a co-staining experiment with anti-phospho-histone-H3 (PH3), a 
specific mitotic marker of chromosome condensation. As shown in Fig. 23, there is a
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partial co-localization o f  the two proteins both in interphase and m itosis indicating that 
probably p i 60 is localized on DNA during mitosis. This confirm s the observation made 
by Gassm ann R., that p i 60 is located on chrom osom e arms during m etaphase [38].
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Fig. 22 p i60 distribution during cell-cycle. Representative immunofluorescence confocal 
images of NIH 3T3 cells stably expressing pi 60-Flag in the mitotic phases indicated on the left. 
Cells were stained with antibodies against Flag (p i60, red), a-Tubulin (green) and DAPI (blue) 
for DNA. Bar = 10 pm.
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I N T E R P H A S E  
A N A P H A S E
Fig. 23 pl60 localizes on DNA during mitosis. Representative confocal images of NIH 3T3 
cells expressing pi 60-Flag in the mitotic phases indicated on the left. The staining was 
performed with anti-Flag (p i60, green), anti-Phospho-Histone-H3 (PH3, red) and DAPI (blue) 
for DNA. Bar = 5 pm.
From these studies, it was evident that p i 60 localizes in a para-chrom osom al region 
during mitosis. I then tested the co-localization with other m arkers that are known to be 
directly present on DNA. Confocal im m unofluorescence staining with CREST, an anti­
serum directed against the inner kinetocore region, recognizing three constitutive 
centrom ere proteins CEN P-A, -B, and -C , showed that p i 60 does not localize in the 
kinetocore region either in interphase or in m etaphase (Fig. 24A). I also tested a possible 
localization o f  p i 60 on telom eres, the most distal region o f chrom osom es, perform ing an 
immuno-FISH. This particular technique allows to see the localization o f  proteins on 
specific DNA regions. I used a FISH probe (PNA) for telom eres and perform ed 
immunofluorescence against p i 60. The staining obtained for p i 60 with this technique 
was slightly different from the previous ones, but nevertheless showed the localization 
o f  p i 60 around the m etaphasic plate in m itosis and dem onstrated that p i 60 does not 
localize in the telom eric region (Fig. 24B).
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Fig. 24 p i60 does not localize at the kinetocore or on telomeres. Representative confocal 
immunofluorescence o f NIH 3T3 cells stably expressing pi 60-Flag in the mitotic phases 
indicated on the left. The staining was performed against Flag (p i60, green), CREST (red, panel 
A), PNA (red, panel B) and DAPI (blue) for DNA. Bar = 5pm.
I then com pared p i 60 staining with the localization o f  other nucleolar proteins which are 
known to be involved in mitosis. During mitosis, N ucleolin is located both at the 
chromosom e periphery and at spindle pole and is im portant for correct chromosom e 
alignment, segregation and spindle formation [77]. As shown in Fig. 25A, p i 60 co- 
localizes with N ucleolin at interphase, but not at metaphase. I also tested 
Nucleophosm in (NPM ) that is essential for m itosis progression, since it is involved in 
proper chrom osom e alignm ent, spindle formation and centrosom e duplication [2]. Also
p i 60 and NPM  co-localize during interphase, but they also partially co-localize during 
m etaphase (Fig. 25B).
In summary, these im m unofluorescence studies show that p i 60 has a para-chrom osomal 
localization during m itosis and is m ainly concentrated on DNA. Therefore I investigated 
the role o f  p i 60 in the cell-cycle.
A
INTERPHASE
METAPHASE
B
INTER PHASE
METAPHASE
Fig. 25 Nucleolar proteins localization during cell-cycle. Representative confocal microscopy 
staining o f NIH 3T3 cells stably expressing pi 60 at metaphase and interphase (indicated on the 
left of the panels). (A) Staining with anti-Flag (p i60, red), anti-Nucleolin (green) and DAPI 
(blue) for DNA. (B) Staining with anti-Flag (p i60, red), anti-Nucleophosmin (NPM, green) and 
DAPI (blue) for DNA. Bar = 5 pm.
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2.2 pl60 knock-down determines proliferation defects
To determine the function of p i60 in cell-cycle, I inhibited its expression by a 
transfection with specific siRNA into HeLa cells. I chose HeLa instead of NIH 3T3 cells 
because I did not obtain good knock-down of the protein (only 50%) in the latter (see 
Results 3, for a more detailed description). Moreover, HeLa cells are a veiy good system 
to study the cell-cycle. I first tested p i60 localization to confirm that p i60 is nucleolar 
also in HeLa cells (Fig. 26A). Analyzing the p i60 sequence I found three sequences that 
match all the requirements for siRNA (highlighted in Fig. 26B). I transiently transfected 
the three siRNAs oligonucleotides and measured the protein level, comparing them with 
control oligonucleotides (High-GC and Medium-GC, see Material and Methods) after 
24, 48, 72 and 96 hours. The silencing was visible already at 24 hours but a major effect 
was obtained after 48 hours (Fig. 26C).
I checked the morphology of HeLa cells 48 hours after transfection in order to identify a 
possible phenotype. As shown in Fig. 27A, all the three siRNAs (and in particular 
siRNA 1) induced high level of cell mortality and hence a lower number of cells.
I then measured the proliferation rate by counting the cells at 24, 48 and 72 hours after 
transfection and observed that with siRNA 1 and 2 there was a consistent lower amount 
of cells at 48 and 72 hours compared to their High-GC control, while siRNA3 had a 
proliferation rate similar to its Medium-GC control (Fig. 27B). Overall, p i60 knock­
down decreased the proliferation rate and increased the number of dead cells.
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AB
1 ctgacctgga agcggctggg gccggagcac acgtgtttcg tgtttcggtg agtgtggcgg
61 agatggagag ccgggatccc gcccagccga tgtcgcctgg agaagcgacg cagagtggcg
121 cccggcctgc cgaccgctat ggcctattga agcacagtcg cgagttcttg gacttcttct
181 gggacattgc gaagcctgag caggagacgc gacttgcggc cacggagaag ctgctggagt
241 atctgcgtgg caggccgaag gggtccgaga tgaaatatgc cctgaagcgt ctaatcacgg
301 gactcggggt cgggcgagaa acagcccggc cctgctacag tttggccctg gcacagctgt
361 tacagtcttt tgaagacctc cccttgtgca gcatcctgca gcagatacaa gaaaaatatg
421 acctgcatca ggtgaagaag gcaatgctga gacctgctct ctttgcaaac ctgtttggag
4 81 tgctcgccct ctttcagtca ggtcggctgg tgaaggacca ggaggcactg atgaagtcgg
541 tgaagctgct gcaggccctg gcccagtacc aaaaccactt gcaggagcag ccccggaagg
601 ccctggtgga catcctctcc gaggtctcga aggccacatt gcaggagatc ctgcccgagg
6 6 1  t c c t c a a a g c  c g a c t t g a a t  j|taatactca gctcccctga acagctagag ctcttcctcc
721 tggcccagca gaaggtgccc tccaagctca agaagctggt gggatccgtg aacctattct
7 81 cagatgagaa tgtccccagg ctggtgaatg tgctgaagat ggccgcctcc tctgtgaaga
841 aggaccgcaa gctgcccgcc attgctctgg acctgctccg cctggcactc aaggaagaca
901 agttcccacg gttctggaag gaggtggtgg aacaagggct gctgaagatg cagttctggc
961 cagccagcta cctgtgtttc cgcctgctgg gcgcggccct gcccctgctg accaaggagc
1021 agctgcacct ggtgatgcag ggagacgtga tccgccatta cggggagcac gtgtgcactg
1081 ctaagctccc aaagcagttc aagtttgccc cagagatgga cgattacgtg ggcaccttcc
1141 tagaggggtg ccaggatgac cctgagcggc agctggccgt gctagtggcc ttctcatctg
1201 tcaccaacca aggcctccct gtcacgccta ctttctggcg ggtcgtgcgg ttcctgagcc
1261 ctccggccct gcagggctat gtggcctggc tgcgggccat gtttctccag ccagacctgg
1321 actccttggt tgacttcagc accaacaacc agaagaaagc ccaggattca tcgctccaca
1381 tgcctgagcg agctgtgttc cggctgagga aatggatcat ctttcgattg gtgagcattg
1441 tggacagcct gcacctggag atggaggagg ccttgactga gcaggtggcc aggttttgtt
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1801 tgaaggagct ggaggcccac tccgcagagg ccagggctgc tgccttccag caccttctgc
1861 tcctcgtggg catccacctc ctcaagtccc ctgcagagag ctgtgacctg ctgggtgaca
1921 tccagacctg catcaggaaa agtctgggag agaagccccg ccggagccgc accaagacca
1981 tcgaccccca ggaacccccg tgggtagagg tgctggtgga gatcttgctg gccctgttgg
2 041 cccagcccag ccacctcatg cgccaggtgg cccggagcgt gtttggccac atctgctccc
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Fig. 26 pl60 down-regulation in HeLa cells. (A) Representative confocal microscope image of 
HeLa cells: anti-pl60 was used to stain pl60 (green) and DAPI (blue) for DNA. Bar = 12 pm 
(B) Nucleotide sequence o f human p i60. siRNA sequences are highlighted and the specific 
controls for each sequence is indicated in the bottom part. (C) Western blot analysis o f p i60 in 
HeLa cells transiently transfected with siRNA for 24, 48, 72 and 96 hours. CTL, HeLa cells not 
transfected; LIPO, cells treated with lipofectamine only; M-GC, cells transfected with the 
control Medium-GC; H-GC, cells transfected with the control High-GC; s il, si2, si3 are HeLa 
cells transfected with siRNAl, siRNA2 or siRNA3 respectively. Tubulin is shown as loading 
control.
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Fig. 2 7  pl60-depleted HeLa cells grow slower than wild-type. ( A )  Representative images of 
HeLa cells 48 hours after transfection. Control untreated (CTL), lipofectamine treated, 
transfected with High-GC or Medium-GC controls and cells transfected with siRNAI, 2 or 3 are 
shown. (B) Measure o f the proliferation rate in HeLa cells under the various conditions 
indicated. Cells were plated in triplicate the day before the transfection at 200000 cells/well (6 
well plate) and counted 24, 48 and 72 hours later. The data are the average of three parallel 
experiments.
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2.3 pl60-depleted cells have a higher degree of apoptosis
I measured the apoptotic potential of HeLa cells 48 hours after transfection with p i60 
siRNAs. Annexin V positive cells (measured by Flow Citometry) at 48 and 72 hours 
were more abundant in HeLa cells treated with siRNAs than their controls. In particular, 
siRNAI had three fold more early-apoptotic cells than its High-GC control (Fig. 28A). 
Similar results were obtained measuring late-apoptotic cells (Annexin V and 7-AAD 
positive cells, not shown). Since siRNAI was the siRNA with the strongest phenotype, I 
used this one for the following experiments.
I also performed an immunoblot analysis to demonstrate apoptosis activation. I used 
total protein extract from HeLa cells transfected with siRNAI or High-GC control at 48 
hours. As shown in the immunoblot of Fig. 28B, there was an activation of Caspase 3 
and Caspase 9 after p i60 silencing. Therefore, the results show that p i60 depletion 
induces apoptosis.
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Fig. 28 p i60 depletion induces an increase of apoptosis. (A) HeLa cells were transiently 
transfected for 24, 48 and 72 hours with the oligonucleotides and conditions indicated on the 
histogram to the right. The number o f apoptotic cells was determined by Flow Citometry 
measuring Annexin V positive cells (early apoptotic cells, left panel, red gate). Control untreated 
cells were given the arbitrary value o f 1. (B) Westem-blot analysis o f HeLa cells transiently 
transfected for 48 hours as follows: CTL (untreated cells), LIPO (treated with only 
lipofectamine), HIGH GC (transfected with High-GC control), siRNAI (transfected with 
siRNAI). The immunoblot was performed with pl60, active Caspase 3 and Caspase 9 
antibodies; Tubulin is shown as loading control.
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2.4 pl60-depleted cells display a variety of the cell-cycle defects
2.4.1 pl60-depleted cells accumulate in the G2/Mphase o f the cell-cycle
From all previous results I concluded that p i60 might be important for cell-cycle
regulation and/or cell division.
To explore the potential involvement of p i60 in cell-cycle progression, I carried out a 
Flow Citometry analysis by labeling control (High GC treated) or silenced (siRNAI 
treated) HeLa cells with 5-Ethynyl-2’deoxyuridine (EdU, a bromodeoxyuridine analog) 
and 7-amino-actinomycin D (7-AAD). EdU is a thymidine analog, which is incorporated 
into newly synthesized DNA strands in the S-phase, therefore its detection is useful to 
estimate the fraction of cells in S-phase; 7-AAD on the other hand detects total DNA. 
After a pulse with EdU, HeLa cells at 48 hours after transfection were stained with anti- 
EdU and 7-AAD. HeLa cells treated with siRNAI showed a decrease of the number of 
cells in S-phase (22 instead of 27%) and an increase of those in G2/M-phase (13 vs 4%) 
compared to control cells (Fig. 29). This suggests a block in G2/M, before cell division.
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Fig. 29 Alteration in cell-cycle distribution in pl60-depleted cells. HeLa cells transfected 
with control High GC or siRNAI at 48 hours after transfection were pulse-labeled with EdU and 
then stained with anti-EdU and 7-AAD and analyzed by Flow Citometry to measure DNA 
synthesis (EdU-FITC, y axis) and DNA content (7-AAD, x axis). The EdU positive cells (S) and 
EdU negative (G0/G1 and G2/M) were analyzed by FCS express software (De Novo Software). 
The percentage o f cells in each phase is shown in the table below the plots and is the mean of 
three independent experiments.
2.4.2 Mitosis structural alterations in pl60-depleted cells
To focus on mitosis, I observed by confocal m icroscopy m itotic HeLa cells transfected 
with High-GC or siR N A I, after staining with anti-Tubulin antibodies (to identify m itotic 
spindle) and DAPI (to label DNA). As shown in Fig. 30A, p l60-depleted  cells have 
abnormal nuclear shapes, with nuclei sm aller than control. M oreover, I m easured by 
confocal m icroscopy the num ber o f  mitotic cells in the two populations: in p 160- 
depleted HeLa cells there were tw ice as m any m itotic figures than in control cells (Fig.
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30B). In the same experim ent I also counted the num ber o f  cells in the different mitotic 
phases. As shown in Fig. 30C, in p i 60 down-regulated cells there was a higher num ber 
o f  cells in prophase and m etaphase com pared to control (-6 0 %  vs -4 0 % ), which 
indicates that there m ight be a delay in com pleting the m itotic process. From the above 
experiments and from the cell-cycle analysis, I conclude that p i 60 down-regulated cells 
are blocked or delayed before cell division.
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Fig. 30 Mitosis impairment in pl60-depleted cells. (A) Representative confocal microscopy of 
HeLa cells control (High-GC) or silenced with siRNAI, 48 hours post-transfection. The staining 
was performed with anti-Tubulin (green) and DAPI (blue). Bar = 23,8 pM. (B) Count of mitotic 
cells after confocal microscopy imaging; cell count = 100. Error bars indicate standard deviation. 
(C) Count of cells in different mitotic phases after confocal microscopy imaging. Mitotic phases 
are indicated on the right; cell count = 100.
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I then focused on the analysis of single mitotic figures and observed several alterations: 
multipolar spindle, incorrect organization of the metaphasic plate, division in three 
daughter cells, etc. (Fig. 31 A). A quantitative analysis (based on the count of altered 
mitotic cells in control- and siRNA-transfected cells after synchronization by double 
thymidine block) showed a two fold higher number of altered mitotic cells in p i60 
depleted cells than in control (Fig. 3 IB). All these results lead to the conclusion that 
p i60 is important for the mitotic process and that its absence determines impairment in 
the completion of the cell division process.
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Fig. 31 p i60 depletion determines mitotic alterations. (A) Representative confocal 
microscopy of HeLa cells transfected with siRNAI for 48 hours. 1) multipolar spindle, 2) and 3) 
altered metaphasic plate, 4) abnormal cytodieresis. The staining was made against Tubulin 
(green) for mitotic spindle and DAPI (blue) for DNA. Bar = 12 pm. (B) Number of altered 
mitosis counted in confocal microscopy images. Cell count = 100.
siRNAI
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2.5 In pl60 silenced cells mitosis is slowed down
I monitored the mitotic process by Time-Lapse microscopy in order to measure the delay 
in mitosis completion. After transfection of HeLa cells with High-GC control or siRNA, 
I synchronized the cells with a double thymidine block and, after the release from the 
block, I examined the cells by Time-Lapse microscopy. Based on the analysis of 60 cells 
for each condition, the mitosis time in pl60-silenced cells was -90 minutes, while in 
control cells it was -70 minutes (Fig. 32A and B). Another interesting observation was 
that among control cells almost 80% of the cells did divide with respect to only 40% of 
the silenced cells. Indeed, many cells (~ 30%) died or did not divide during the period 
analyzed (Fig. 32C). I conclude that p i60 down-regulated cells have a longer mitotic 
time because of abnormalities in cell division and the majority died due to accumulation 
of mitotic alterations not compatible with life.
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Fig. 32 pl60-depleted cells have a longer mitotic time. (A) White-field Time-Lapse video 
imaging of HeLa cells transfected with siRNAI for 48 hours and synchronized with a double 
thymidine block. Images were taken 8 hours after the release from the block (mitosis start) with 
Oko-Vision Time Lapse microscope for 18 hours; images were taken every 5 minutes. (B) 
Measure of mitotic time with Time-Lapse video imaging. Cell count = 40. (C) Percentage of 
cells dividing, not dividing or died during the period analyzed by Time-Lapse microscopy; cell 
count = 60.
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2.6 No variability in karyotype for pl60 down-regulated cells
Twenty-five metaphase spreads were analyzed and 10 karyotypes were elaborated for 
each cell line. The karyotypes from the HeLa cell line, both control and pl60-silenced, 
had up to 83 chromosomes (ranging from 70 to 83; modal number 73). All samples were 
similar for chromosomal gains, losses and structural abnormalities. No significant 
variation in chromosome condensation or increase of chromatids and chromosomes 
breaks were observed independently of cell treatment, suggesting no effect of p i60 
silencing on chromosome number and structure (Fig. 33). An interesting point was that 
HeLa cells silenced and synchronized in mitosis had a five fold reduced number of 
metaphases (over 50 metaphases counted in the control, only 10 were found in silenced 
cells), indicating that pl60-depleted cells have difficulties to enter in mitosis. This 
agrees with the above results. I conclude that the alterations induced by pi 60-depletion 
are most of the time lethal and therefore they do not apparently affect the karyotype.
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Fig. 33 pl60-depleted HeLa cells do not show alterations in karyotype. Metaphasic spread of 
HeLa cell control (High-GC) and pl60-depleted (siRNA 1) are compared.
2.7 Gene expression profiling in pl60-depleted HeLa cells
2.7.1 Microarray experiment
I performed a gene expression profiling analysis in order to investigate which pathways 
are altered after p i60 silencing. I used Affimetrix microarrays to compare HeLa cells 
transfected with High-GC control or siRNAI (three biological replicates for each 
condition) and I analyzed 28829 genes. After statistical analysis, I found 853 
differentially expressed genes: 71,4% were down-regulated and 28,6% were up- 
regulated (Fig. 34A).
Total number of detected genes = 28829  
Differentially expressed genes = 853 (2 ,9 6 % )
Genes up = 244 (2 8 ,6% )
Genes down = 609 (71 ,4% )
Fig. 34 Statistical analyses o f microarray experiment of control vs pl60-depleted HeLa 
cells. In the table are indicated the number o f genes analyzed and the differentially expressed 
genes found.
Once the differentially expressed genes were identified, I wanted to discern which 
molecular mechanisms and pathways were altered. I used the DAVID software and ran a 
functional annotation clustering of the differentially expressed genes in pl60-depleted 
HeLa cells. For this analysis I considered only the categories with Benjamini value <10“ 
3 statistically significant. Fig. 35A and C shows the main biological processes involved,
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while in Fig. 35B and C are shown the main cellular components. The m ajority o f  the 
differentially expressed genes is involved in cell-cycle and m itosis (-56% ), but DNA- 
dam age and stress response (-11 ,5% ) and apoptosis (-19 ,2% ) are also highlighted. This 
result is also confirmed by the main cellular com ponents involved that are: chromatin, 
nucleus, m itotic structures and m icrotubules (-49 ,8% ) (Fig. 35 C). W hat clearly emerges 
from further analyses is that p i 60 is involved in the cell-cycle, in particular in the 
mitotic process. My interpretation is that w ithout p i 60 cells try to divide and proliferate 
but are blocked at the stage o f  m etaphase and thus are directed to apoptosis.
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Fig. 35 Functional annotation clustering of the significantly regulated genes in pi 60- 
depleted HeLa cells. Functional clustering was performed with DAVID software. To rank their 
biological significance, the p-value was used. “Counts” is the number o f differentially regulated 
genes within each cluster. (A) In this table are listed the main biological processes altered. (B) In 
this table are annotated the main cellular components altered. (C) Schematic representation of 
the biological processes (left) and cellular components (right). These diagrams were obtained 
grouping the clusters in the categories indicated on the right o f each diagram.
2.7.2 Validation o f  Gene Expression experiment by Real-Time PCR  
I focused then on the single genes de-regulated in these categories and validated some o f  
them to confirm  the m icroarray experiment. I tested six genes am ong either p i 60 
interactors, genes involved in cell-cycle regulation or DNA dam age response (Table III).
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Table HI. Selection of genes differentially expressed in pl60-depleted HeLa cells vs control 
HeLa cells. Genes in bold are the ones selected for Real-Time PCR.
Gene Symbol Fold Change 
(silenced vs control)
Molecular function
P160 -4,13
JUN 3,03 Repressed by p i60; transcription factor; 
frequently altered in human cancer.
NFKB2 2,12 Repressed by p i60; transcription factor.
CDKN1A 4,3 Cyclin-dependent kinase inhibitor (i.e. 
cyclin-CDK2 or 4); regulates Gl/S 
transition: in stress condition block cell 
before S-phase.
RBL2 -2 Involved in Gl/S transition regulation.
RBBP8 -2,97 Binds Rb and regulates cell proliferation.
MAPK9 -2,16 Serine/threonine kinase activity; it mediates 
stress response.
TGFp2 2,02 Involved in proliferation, differentiation, 
cell-cycle progression and apoptosis.
AKAP -2,9 Involved in apoptosis.
VAV3 -2,89 Involved in apoptosis and cytokinesis.
GADD45A 2,13 Induced in response to stress and DNA- 
damage.
GADD45B 2,69
TOP2A -2,16 Required for correct chromosome 
condensation, chromatids separation and 
thus to prevent DNA-damage.
TOP2B -3,4
TP53BP2 -2,3 Regulates apoptosis and cell growth.
WRN -2,5 Nucleolar protein involved in double-strands 
breaks repair.
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With the same RNA preparation used for the m icroarray experim ent I ran a Real-Time 
PCR for p i 60 (Fig. 36) and confirmed that it was 80% down-regulated. I also checked 
JUN and N F-kB2, known to be repressed by p l6 0  [32,97]; these proteins are also 
important for cell proliferation and indeed are overexpressed in coincidence with p i 60 
silencing. I checked CDK N1A  that encodes a cyclin-dependent kinase inhibitor and 
regulates the G l/S  transition; GADD45B was also tested because is an im portant 
mediator in DNA dam age response and TOP2B, a topoisom erase involved in 
chromosom es condensation and chrom atids separation. Real-Tim e PCR confirmed that 
CDKN1A and GADD 45B were increased and TOP2B was decreased in p l60-depleted  
cells. These data overall confirm  the down-regulation o f  p i 60, the strong decrease in its 
associated transcriptional activity, the block o f  the cell-cycle and the induction o f  DNA 
or chromosom e dam age w ith the activation o f the DNA -dam age response.
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Fig. 36 Gene expression profile by Real-Time PCR. Real-Time PCR was performed on 
control (High-GC) or pl60-depleted HeLa cells (siRNAI) with the same RNA samples used for 
the microarray experiment. Two biological replicates were used for each condition and the 
experiment was performed in triplicate; control levels (CTL) were given the arbitrary value of 1. 
The bars indicate standard deviation and ** means p < 0,01 while ***, p < 0,001 (t test).
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Summary of results 2
In this second section I have demonstrated that p i60 distributes in a para-chromosomal 
region during mitosis and that is involved in the mitotic process. In fact, after p i60 
depletion cells showed a lower proliferation rate, a higher degree of apoptosis, 
accumulation in G2/M phase of cell-cycle with structural alterations in mitosis and a 
slower mitotic rate. A surprising result was the “apparently” normal karyotype but, since 
wild-type HeLa cells present an altered number of chromosomes and many alterations, it 
was also difficult to underline a difference between the samples analyzed. Moreover 
gene expression profiling demonstrated that without p i60 many genes involved in cell- 
cycle regulation, DNA damage, mitosis and cell death are de-regulated, highlighting an 
important role of this protein as a late cell-cycle regulator.
The data presented in Fig. 33 were obtained through a collaboration with L. Pecciarini 
(Pathology Unit of San Raffaele Hospital, Milan, Italy) and Fig. 34 from the Microarray 
Facility of Cogentech (IFOM, Milan, Italy).
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3. Role of p!60 in tumorigenesis
3.1 Fifty percent reduction of pl60 does not result in changes in the cell-cycle
I demonstrated that a strong down-regulation of pl60 impairs the cell-cycle and 
determines cell death. A condition in which the reduction of p i60 was lower, compatible 
with life, might help to better understand the role of this protein. Since NIH 3T3 cells 
silenced for p i60 with five different shRNAs never gave a reduction of the protein of 
more than 50%, I used this to model the “heterozygous” condition. Fig. 37A shows the 
immunoblot against p i60 of NIH 3T3 cells stably infected with five different p i60 
shRNAs. shRNAl and 3 were performing better, giving more or less fifty percent 
reduction of the protein (61 — 55% pl60 reduction). I tested shRNAl for cell-cycle 
distribution and apoptosis in order to compare these cells with pl60-depleted HeLa cells. 
In Fig. 37B it is shown a bivariate FACS analysis using EdU incorporation and 7-AAD 
staining on NIH 3T3 cells treated with the non-target vector (NT) or with shRNAl. 
After EdU pulse, NIH 3T3 cells were stained with anti-EdU to detect EdU incorporation, 
and with 7-AAD to detect total DNA. shRNAl treated cells showed no differences in 
cell-cycle distribution compared to their control. I also performed an Annexin V staining 
on the same population and analyzed by FACS the number of apoptotic cells (Annexin 
V positive cells). As shown in Fig. 37C, there were no significant differences between 
non-target control and p i60 shRNA. In conclusion, NIH 3T3 cells with a fifty percent 
reduction of p i60 level show no differences in cell-cycle.
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Fig. 37 p i60 down-regulated NIH 3T3 cells show no changes in cell-cycle. (A) Immunoblot 
analysis o f NIH 3T3 cells not infected (CTL), infected with non-target (NT), or with 
shRNA 1,2,3,4,5 lentiviral vectors (SHI,2,3,4,5 respectively). Total protein extracts were 
immunoblotted against p i60 and tubulin as loading control. The numbers on the top o f the 
immunoblot indicate the amount o f the protein quantified after densitometric analysis; values 
were compared to NT, non-target control (100%). (B) Cell-cycle distribution in NIH 3T3 cells 
infected with non-target vector (NT) or shRNAl (pl60sh) measured with EdU and 7-AAD 
incorporation by FACS analysis. (C) Measure o f the number o f apoptotic cells (Annexin V 
positive cells) by Flow Citometry in NIH 3T3 cells control (NT) or silenced with shRNAl 
(p!60sh). Error bars indicate standard deviation.
3.2 A small reduction in pl60 level favors cell transformation
It is already published for other nucleolar proteins that a fifty-percent reduction of their 
level induces accumulation of genetic alterations (chromosomal rearrangements, 
deletions, etc.) that favor cell transformation. This was well demonstrated for 
Nucleophosmin (NPM) where in the heterozygous NPM+/' mice there is genomic
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instability (for incorrect centrosome duplication) that favors cell transformation. 
Moreover, all human tumors with rearrangements/deletions in the NPM1 locus express 
half the amount of NPM [43]. I performed a literature search for tumors associated with 
p i60. Using the Mitelman database (http://cgap.nci.nih.gov/Chromosomes/Mitelman) I 
found that the p i60 locus was translocated in 406 human tumors and that the most 
recurrent type of tumors were leukemias (148) and lymphomas (82). The locus for pi 60, 
17pl3.3, is also frequently deleted in solid tumors [61]. I thought that also in NIH 3T3 
cells with fifty-percent less p i60 there might be genomic instability favoring cell 
transformation. I first performed a karyotype analysis on control or p i60 down-regulated 
(shRNAl) NIH 3T3 cells but also in this experiment (like for the HeLa kaiyotype) I did 
not detect any significant difference between the two populations (data not shown), 
probably due to an already altered karyotype.
I decided anyway to study tumorigenesis in this “heterozygous” cell line. NIH 3T3 cells 
are a good system to study oncogene-induced tumorigenesis and can be transformed by 
active Ras alone (while non-immortalized cells require the action of two oncogenes). If 
p53 is diminished (and this happens when an oncosuppressor is absent), the 
transformation induced by Ras is even stronger. I studied proliferation in NIH 3T3 cells 
infected with control non-target and shRNAl and 3 (the two constructs performing 
better) with and without the Ras-Vall2 oncogene. I measured cell proliferation with a 
crystal violet assay counting the cells every 2 days for 10 days. As shown in Fig. 38, in 
the absence of Ras, shRNAl and 3 treated cells proliferated faster than control, 
especially shRNA3 (p < 0,001 at 10 days). Upon infection of the cells with Ras-Vall2, 
shRNA3 induced a significant increase in cell proliferation (p < 0,001).
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Fig. 38 p i60 down-regulated NIH 3T3 cells proliferate more than wild-type. Growth curve 
o f control NIH 3T3 cells infected with non-target (NT), shRNA 1,3 (SHI,3) and Ras-Vall2 
infected cells (bottom panel). Crystal violet assay performed for 10 days counting the cells in 
triplicate every 2 days. **, p < 0,01; ***, p < 0,001 (t test).
I perform ed also a soft agar assay to test w hether p i 60 also favors the form ation o f  
colonies in agar. I analyzed non-target shRNA (NT), shR N A l and shRNA3 infected or 
R as-V all2  and shRNA double-infected NIH  3T3 cells. In the first experim ent, plating
50,000 cells in each well in triplicate (Fig. 39A), Ras induced colony formation both in 
N T and shRNA treated cells already at 9 days after plating. However, the num ber o f  
colonies was significantly higher in NIH  3T3 cells with a lower level o f  p i 60 (shR N A l
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and 3). I repeated the experiment plating a lower number of cells: 5,000 cells in each 
well, using the same cell lines, and in parallel I also infected NIH 3T3 cell with Myc. As 
shown in the histogram in Fig. 39B, 15 days after plating there were almost no colonies 
in the untreated samples while in Ras and even more in Myc infected cells there was a 
significant number of colonies, especially in the shRNA samples.
All these data confirm that a lower amount of pi 60 in the cells favors cell transformation 
and that this effect is generalized and not only linked to Ras over-expression. Overall, 
the data could indicate that p i60 has a tumor suppressor function.
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Fig. 39 A reduction in pl60 level favors cell transformation. (A) Soft agar colony assay with 
NIH 3T3 cells infected with NT, shRNAl or shRNA3 vectors with or without a co-infection 
with Ras-Vall2. 50,000 cells were plated in triplicate and the images were taken 9 days after 
plating. (B) Histogram that summarizes the soft agar colony assay performed with NIH 3T3 cells 
infected with NT, shRNAl or shRNA3 with or without a co-infection with Ras-Vall2 and Myc.
5,000 cells were plated in triplicate and colonies were counted after 15 days using Image J 
software.
105
Summary of Results 3
In this last section I showed that a fifty percent reduction in p i60 level favors NIH 3T3 
cell proliferation and transformation. In fact, this condition increases the proliferation in 
association with Ras, and results in the formation o f a large number of colonies in soft 
agar when there is an overexpression o f Ras or Myc oncogenes. This highlights a 
possible role o f p i 60 as a tumor suppressor. It is very interesting to notice that p i 60 is 
an interactor o f Prepl, which is also a tumor suppressor [75]. It will be important, 
therefore, to verify the cell-cycle dependence of the P repl-pi 60 interaction.
The data presented in this section are unpublished.
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DISCUSSION
p i 60 myb binding protein la  is a nucleolar protein, the function o f which is largely 
unknown. The presence in its structure o f many leucine-charged domains and leucine- 
zipper-like domains, involved in protein-protein interaction, justifies the finding that 
transcription factors (e.g. c-myb) are among its interactors [124]. p i 60 is a ubiquitous 
protein, highly conserved among species, that shares a high degree o f similarity with 
yeast POL5, a nucleolar protein involved in rRNA synthesis [119]. Another interesting 
feature o f p i60 is its localization on human chromosome 17pl3.3, a region frequently 
involved in loss of heterozygosity observed in many tumors [61]. In this thesis work I 
demonstrated an involvement o f p i 60 in the cell-cycle and a putative role of this protein 
as a tumor suppressor.
I also studied Prepl, an homeodomain transcription factor essential for embryonic 
development. In particular it influences hematopoiesis, angiogenesis and oculogenesis 
[37]. It is also involved in apoptosis [86,87] and in tumorigenesis as a tumor suppressor 
[75]. Prepl functions as a transcription factor when it is translocated to the nucleoplasm 
through its binding to Pbx. Here it can interact with Hox (or other) proteins and 
increases their affinity for DNA and their transcriptional activation. By Tandem Affinity 
Purification (TAP) [23] we found that p i 60 is a specific Prepl interactor capable o f 
inhibiting Prepl transcriptional activity by preventing Pbx binding [24].
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1. pl60 is a direct Prepl interactor that inhibits its 
transcriptional activity
p i 60 binds through its N-terminal region to the HR1 domain of Prepl. This domain is 
essential for Prepl function since it is the region that makes contact with Pbx and 
increases the binding of the Pbx/Hox heterodimer and its transcriptional activity. In 
particular p i 60 binds a leucine-rich region in the HR1 domain, a LXXLL motif (Fig. 14 
and 15), i.e. the same protein sequence that p i 60 uses to bind Myb and PG C la [30,94]. I 
also showed, by a Luciferase assay, EMSA and Real-Time PCR (Fig. 17 and 18) that 
Prepl activity was significantly decreased by p i 60. In particular, p i60 competes with 
Pbx in the binding to Prepl hence inhibiting the interaction with Pbx and the resulting 
transcriptional activation. This demonstrates that p i60 is a Prepl regulator.
Prepl lacks a nuclear localization signal, but translocates to the nucleoplasm through its 
binding to Pbx. On the other hand, p i 60 is mainly located in nucleoli and only 5% was 
found in the nucleoplasm. I showed that Actinomycin D treatment, that causes the 
inhibition o f RNA polymerase I, determines the shuttling of p i60 from nucleoli to 
nucleoplasm and allows the visualization of the co-immunoprecipitation and co­
localization of the two proteins (Fig. 20 and 21). However, at least in the untreated F9 
cell line, Prepl is observed also in nucleoli in co-localization with p i60. I also studied 
the co-localization of p i60 and Prepl during mitosis, since it is a physiological 
condition that causes disruption of nucleoli at the onset of prophase and the release of 
nucleolar proteins in the nucleoplasm [73]. However, in these conditions co-localization 
of the two proteins was not detected: p i 60 has a peculiar para-chromosomal localization, 
typical o f many nucleolar components, while Prepl is more dispersed (Fig. 19). It is
possible, although unlikely, that minor amounts o f Prepl are present in the nucleolus and 
that some interactions, functionally relevant, but not visible with this technique, indeed 
take place in both nucleoli and chromosomal areas.
The relation between Prepl and p i60 is also important for glucose metabolism, p i 60 is 
an inhibitor o f the transcription factor PG C la that regulates glucose uptake by 
promoting the synthesis of GLUT4 glucose receptors. At low levels of p i 60, PG C la 
increases and induces GLUT4 expression [1,88]. In fact P rep l1/1 mice show an increased 
sensitivity to insulin due to increased GLUT4 and are resistant to diabetes [96]. 
Moreover, p i 60 seems to be protected from degradation by P rep l: at low levels of Prepl 
(like in the P rep l1/1 mice) there is also a low level o f p i 60 and this is restored by 
proteasome inhibition.
In summary, I identified p i60 myb binding protein la  as a new Prepl inhibitor that 
modulates its transcriptional activity. How the two proteins interact and the importance 
o f Prepl in p i 60 function at mitosis is, however, still not clear.
2. pl60 is involved in cell-cycle regulation
p i60 is a nucleolar protein that interacts with many transcription factors: c-Myb, c-Jun, 
PG Cla, AhR and NF-kB [30,57,97,124], but its function is still not clear. The fact that it 
interacts with many transcription factors suggested that p i 60 might be a co-regulator o f 
transcription by both polymerase I and II [124]. Another hypothesis is that p i 60 is part 
of a large complex that regulates ribosome biogenesis in the nucleolus. Inhibition of 
ribosomal biogenesis determines the proteolytic cleavage o f p i 60 into p67 or p i40 that
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translocate to the nucleoplasm and form a complex with many transcription factors 
(Myb, PG C la, NF-kB, etc.) affecting cell-cycle arrest and apoptosis [134].
Here I demonstrated that p i 60 is involved in the cell-cycle. p i60 has a para- 
chromosomal localization during mitosis: it distributes around the metaphasic plate and 
concentrates in two regions on the side o f the plate, in agreement with p i 60 localization 
on chromosomes arm during mitosis [38] (Fig. 22). Due to its particular localization, I 
studied the role o f this protein in cell division. After p i 60 silencing, as shown in Figures 
27 and 28, cells grow slower and die mainly of apoptosis. Interestingly this agrees with 
the observation that p i 60 KO embryos die at the stage of blastocyst (Keough R., 
personal communication).
By studying cell-cycle distribution, it was evident that, after p i60 depletion, HeLa cells 
accumulate in the G2/M phase and display an increased mitotic index (Fig. 29 and 30). 
In particular, I noticed an increase number o f cells in prophase and metaphase with 
respect to anaphase and telophase. This indicates that cells can start proliferating, 
replicate their DNA content but are then blocked at the stage o f chromosomes 
segregation. Chromosome segregation is well controlled by the Spindle Assembly 
Checkpoint (SAC), a protein complex located at the level of kinetocores that ensures the 
fidelity o f chromosome segregation in mitosis. I f  chromosomes are not properly attached 
to the spindle or not aligned to the metaphasic plate the SAC complex (in particular 
MAD2) binds cdc20 that can no longer bind and activate APC/C and hence determines a 
delay of the subsequent anaphase. If  the problem is solved, the cell can proceed with 
chromosomes segregation, otherwise apoptosis is induced [92]. In my model, p i 60- 
depleted HeLa cells might not divide because SAC is activated. Checking several
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metaphasic plates by immunofluorescence, I noticed structural alterations (Fig. 31) and 
found that division was blocked or, at best, delayed (Fig. 32). These data confirm that 
the cells try to divide but often they are unable to do so. Consequently they die o f 
apoptosis or, in a few cases, they proceed through division accumulating alterations. 
This was not visible with kaiyotype analysis probably because the cell system used 
(HeLa and NIH 3T3 cell line) has already a very altered karyotype. However, the 
sensitivity o f p i 60 down-regulated NIH 3T3 cells to oncogene-induced transformation, 
shown in the last part of my Results, might be interpreted in this way: without p i60, 
cells accumulate genetic alterations that favor tumorigenesis (see later). Thus, p i 60 is 
involved in controlling cell-cycle progression and, in particular, it seems to be important 
for chromosome segregation and cell division.
Very recently a paper was published that supports this idea. Perrera et al. (2010), 
claimed that p i 60 is a novel substrate of Aurora B. Aurora B is a serine-threonine kinase 
involved in centrosomes segregation and maturation, spindle assembly and stability, 
chromosomes condensation, congression and segregation, cytokinesis [68,127]. p i 60 is 
phosphorylated by Aurora B in serine 1303 (C-terminal part) and indeed it is 
phosphorylated in vivo during mitosis. For this reason they studied also the cell-cycle 
and obtained results in line with ours: a decrease in p i 60 level led to a decreased 
proliferation rate, longer mitosis time and mitotic spindle defects [101].
A further confirmation of this idea has also been obtained by the gene expression 
studies. The microarray experiment suggested that silencing of p i 60 determines mainly 
alterations in transcription o f the cell-cycle, mitosis, DNA damage response and cell 
death pathways (Fig. 35). These results were confirmed by Real-Time PCR and were
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consistent: p i60 was down-regulated in treated samples versus control, as expected, as 
HeLa cells were treated with a siRNA for p i 60. JUN and NF-kB, known to be repressed 
by p i 60, were up-regulated in treated samples. I confirmed also the expression data of 
CDKN1A, GADD45B and TOP2B. The alteration of their expression and of the genes 
listed in Tab. Ill, implies that there is a de-regulation o f cell-cycle and apoptosis. These 
data emphasize that, in response to p i 60 depletion, there is an activation o f the genes 
involved in cell-cycle control and mitosis probably in response to an alteration of this 
process. This determines the activation o f the apoptotic pathway in cells that cannot 
repair the damage. Thus, p i60 is a transcription factor binding protein involved in cell- 
cycle progression. Its peculiar phenotype led me to investigate also a possible 
involvement in neoplastic transformation.
3. pl60 is a putative tumor suppressor
The NPM KO determines mitotic alterations, proliferation defects and apoptosis, while 
an heterozygous condition determines genomic instability that leads to cell 
transformation [43]. Given this similarity and the fact that the p i 60 gene is frequently 
translocated in human cancers (as analyzed from the Mitelman database), I studied the 
consequences of a 50% reduction o f the protein. NIH 3T3 cells infected with lentiviral 
vectors expressing pi 60 shRNA show 50% of the protein, no alteration in the cell-cycle 
distribution and apoptosis, but grow slightly faster than the parental counterparts (Fig. 
37 and 38).
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A striking result was obtained when the oncogenes Ras or Myc were co-infected with 
the shRNA lentivectors, p i60 down-regulated NIH 3T3 cells grew faster than control 
and formed more colonies in a soft agar assay (Fig. 39). These data led me to think that 
p i 60 might have a role in tumorigenesis, because the accumulation of genetic alterations 
during cell division may accelerate the onset of the mutations required for 
tumorigenesis. This can be indicative o f a p i 60 role as tumor suppressor. This 
phenotype may also be due to a clonal selection and hence unrelated to p i 60 decrease, 
as I did not analyze this point directly. Preliminary data on nude mice subcutaneous 
injection of NT or p i60 down-regulated NIH 3T3 cells again demonstrate that under 
conditions of p i 60 down-regulation, cells become more tumorigenic, giving rise to the 
formation of bigger tumors.
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Concluding remarks and future perspectives
In summary, in this thesis I have demonstrated that p i60 is a Prepl interactor and 
inhibitor and it is involved in cell-cycle regulation.
I showed that p i 60 and Prepl directly interact and that this binding (demonstrated by 
co-immunoprecipitation and co-localization) is visible only in overexpression o f one of 
the two partners or in stress conditions. This indicates that probably the two proteins 
physiologically interact but just a minor fraction o f them is involved in this binding. 
However this interaction seems to be functionally relevant since p i 60 can inhibit Prepl 
transcriptional activity. Overall I think that there are few aspects in this first part of my 
results that need to be further investigated. First o f all, even if  strong evidence suggests 
that Prepl and p i60 directly interact, another experiment, to finally prove this binding 
can be performed. In fact p i 60 was in-vitro synthesized with a TNT T7 Quick coupled 
transcription-translation system (Promega) that employs the rabbit reticulocyte lysate 
containing the eukaryotic protein machinery required for translation. This technique is 
very convenient because it allows to obtain a good amount o f radio-labeled protein but 
the mix contains eukaryotic proteins that can interfere or facilitate the binding of two 
proteins. A pull-down made with proteins prepared in prokaryotic organism, such as 
yeast, could be useful in order to exclude that the interaction is not direct but part o f a 
complex. Another key point that needs to be further investigated is p i 60 localization, 
p i 60 is mainly located in the nucleoli but probably has a dynamic localization and can 
shuttle between different compartments, demonstrated also by the fact that it was also 
found in the nucleoplasm. Therefore a more accurate analysis o f p i60 localization can
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be performed using FLIP (Fluorescence Loss In Photobleaching) or FRAP 
(Fluorescence Recovery After Photobleaching), techniques that allow to monitor the 
movement o f proteins inside cells. In this way it will be possible to elucidate p i 60 
shuttling and maybe understand also where it co-localizes with Prepl or find other 
cellular compartments where the protein might concentrate and exert a function. For 
example p i 60 staining suggests that it can localize in Cajal bodies, subnuclear structures 
important for snRNPs biogenesis [95]. A co-staining with coilin will uncover this point.
With this thesis work I also discovered that p i 60 functions as a cell-cycle regulator, 
since p i 60 is essential for a proper cell division. A major reduction in p i 60 level 
determines cell-cycle alterations, apoptosis and hence a lower proliferation rate. A small 
reduction, however, determines accumulation o f alterations and favors cell 
transformation. Therefore my hypothesis is that in the absence of p i 60, DNA damage 
may occur due to problems in DNA replication or cell division. Cells slow down their 
cell-cycle and accumulate in metaphase to repair the damage. However, in the absence 
of p i 60, DNA repair is not achieved: hence growth arrests and cells die for apoptosis. A 
fifty percent reduction in p i60 levels is however compatible with cell division, despite 
the accumulation of genetic alterations by cells. These mutations may favor cell 
transformation and uncontrolled proliferation that are at the basis of tumor formation. 
Hence my data have uncovered a new function for p i 60 as a cell-cycle regulator and 
possibly as tumor suppressor. To validate this hypothesis I think it will be useful to 
perform the rescue of the phenotype, reintroducing p i 60 into silenced Hela cells. In fact 
my experiments were done with a transformed cell line with transiently transfected
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siRNAs that can interfere with the final result. Finally it will be helpful to perform p i 60 
silencing in a primary cell line to monitor genetic instability (probably responsible o f the 
cell transformation) not visible in Hela and NIH 3T3 cell lines.
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APPENDIX
I. Study of pl60MBP sumoylation 
The Sumoylation process
Sumoylation is a process similar to ubiquitination but instead of inducing the target 
protein to degradation, it modifies the substrate activity or function. This process is 
mediated by SUMO (Small Ubiquitin-like Modifier). The sumoylation process consists 
of three steps (Fig. A l):
- ATP-dependent activation of SUMO by the E l enzyme
- conjugation by the E2 enzyme
- binding to the substrate with the help o f the E3 ligase.
Sumoylation is a reversible process; SUMO can be deconjugated from the substrate by 
the action o f desumoylases (SENP) [136].
11 s 
3 f , . i
Desumoylases
Fig. Al Sumoylation process. Schematic representation o f the sumoylation process; the 
enzymes involved are indicated [136].
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The primary function of sumoylation is in the nucleus: it regulates transcription, 
modulates nuclear trafficking, genomic stability and chromosomal integrity. 
Sumoylation can also regulate protein-protein interaction and protein localization.
Aim of the work
I decided to study sumoylation because p i 60 was found between the endogenous 
sumoylated proteins upon proteasome inhibition [85]. After proteasome inhibition the 
SUMO-1 conjugates accumulates in the nucleoli and this allowed the identification of 
several putative SUMO substrates by quantitative proteomics; among them, p i 60. 
Sumoylation can be the process that determines p i60 translocation from nucleoli to 
nucleoplasm where it interacts with Prepl; I decided then to study this process in details.
Materials & Methods
- Cell culture and treatments
NIH 3T3 cells were cultured as described in Material and Methods. Cells were infected 
with pRufiieo-p 160-Flag as described previously.
- In vitro sumoylation reaction
NIH 3T3 cells nuclear extracts were prepared as described previously and incubated for 
30 minutes at 25°C with HIS-SUMO 40 ng (SUMO conjugated with Histidine tag), 
Aosl/Uba2 20 ng (E l activating enzyme), Ubc9 10 ng (E2 enzyme), inorganic 
pyrophosphatase 0.6Units, ATP 10 mM, Tris-HCl 50 mM pH 7.6, MgC12 10 mM. The 
reaction was then loaded on a polyacrylamide gel and SDS-PAGE was performed as 
described previously.
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- Co-immunoprecipitation and in-vitro translation o f  proteins was performed as 
described previously.
Results
1. P160 is sumoylated in vitro and in vivo
In order to validate p i 60 sumoylation an in vitro sumoylation reaction was performed. 
As shown in Fig. A2 A, after adding SUMO to the nuclear extract o f NIH 3T3 cells 
stably expressing p i 60-flag, there was an upward shift o f the band representing p i 60, 
indicating that p i 60 was sumoylated. We tested this hypothesis also in vivo, performing 
p i 60 immunoprecipitation in NIH 3T3 cells overexpressing p i 60-flag, followed by a 
blot with anti-SUMO antibody. As shown in Fig. A2 B, p i 60 was sumoylated also in 
vivo because the immunoprecipitated band was detected with SUMO antibodies;
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W.B. anti-sumo W.B. anti-Flag
Fig. A2 p l6 0  sum oylation. (A) In vitro sumoylation reaction o f NIH 3T3 cells nuclear extracts 
(NE): NE is untreated nuclear extract; CTL is NE incubated with sumoylation mix but without 
SUMO and REACTION is NE incubated with the whole sumoylation mix. (B) Co- 
immunoprecipitation o f p i 60 and SUMO in NIH 3T3 cells overexpressing pi 60-flag. The 
reaction was performed with M2 anti-Flag beads and the immunoblot was performed with anti- 
SUMO and anti-Flag antibodies as control. CTL are NTH 3T3 cells not infected with p i60.
2. Detection of the SUMO binding site
We wanted to find the SUMO binding site in order to create p i60 mutants that cannot 
bind SUMO, useful to discover the function o f this post-translational modification in 
p i60. We used SUMOplot Analysis Program (Abgent), a software that calculates the 
most likely SUMO binding sites. The majority o f the sites found were in the N-terminal 
part o f the protein and in particular we chose an AKPD motif (position 41-44, score 
0,79). We mutated the lysine (K) to arginine but apparently there was no change in the
NE CTL REACTION
-175KDa
W.B. anti-p160
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sumoylation state. This experiment needs to be repeated, possibly trying to mutate 
another SUMO binding site.
We prepared also p i60 deletion mutants on which an in-vitro sumoylation reaction was 
performed after in-vitro translation. Since the most likely binding site was in the N- 
terminal region we used only the p i 60 fragments 1-200, 200-400 and p67 (1-580). After 
the reaction we tested p i 60 sumoylation. The result showed sumoylation only in the 1- 
200 fragment and in p67, suggesting that the 1-200 region contained the sumoylation 
site (Fig. A3).
SUMO SUMO+E kDa
175-
80 -
58 - 
■46 -
30 - 
25 -
1-200
SUMO
2 0 0 -4 0 0  2 0 0 -4 0 0  p 6 7  p67
CTL SUMO CTL SUMO
IBSM igl
Fig. A3 The SUMO binding site is located in the N-terminal region of pl60. In vitro 
sumoylation reaction o f in v/Yro-translated pi 60 fragments: 1-200, 200-400 and p67. In the left 
panel is shown the coomassie staining o f the gel showing that sumoylation happens only when 
sumoylation enzymes are added to the reaction: SUMO indicates that only SUMO was added to 
the proteins and SUMO+E indicates that also the sumoylation enzymes were added. On the right 
is shown the autoradiography o f the different reactions where CTL indicates the control reaction 
without SUMO and SUMO the reaction with it.
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Summary
In conclusion we can say that p i60 is sumoylated. After finding the protein among the 
nucleolar endogenous sumoylated proteins after proteasome inhibition, we demonstrated 
this post-translational modification both in vitro and in vivo. We also demonstrated that 
SUMO binds the N-terminal part of p i 60, i.e. the same region involved in Prepl 
binding. We need now to understand which is the function of this modification. One 
hypothesis is that p i 60 sumoylation takes place in the nucleoli and this allows the 
protein to translocate in the nucleoplasm where it is de-sumoylated and can interact with 
Prepl or other transcription factors. P I60 then returns again into nucleoli.
This work contains unpublished data and was done in collaboration with A. Bachi’s 
group (DIBIT2, San Raffaele Hospital, Milan, Italy).
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